var title_f13_15_13552="Erythema gyratum repens";
var content_f13_15_13552=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F58124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F58124&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Erythema gyratum repens",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 261px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Callen, Jeffrey. Color Atlas of Dermatology. WB Saunders 2000. p.70. Copyright &copy; 2000 Elsevier Science.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13552=[""].join("\n");
var outline_f13_15_13552=null;
var title_f13_15_13553="Lafutidine: International drug information";
var content_f13_15_13553=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"10\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Lafutidine: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4302636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Stogar (JP)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F3902771\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Histamine H",
"       <sub>",
"        2",
"       </sub>",
"       Antagonist",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F3466548\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of gastric, duodenal, and stomal ulcers; acute gastritis and acute exacerbation of chronic gastritis; preanesthetic",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F3466550\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastritis (acute) and acute exacerbation of chronic gastritis: 10 mg/day after evening meal or before bedtime",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Preanesthetic: 10 mg prior to bedtime the day before operation and 2 hours before introduction of anesthetic on day of operation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ulcers, gastric, duodenal, and stomal: 10 mg twice daily, once after breakfast and once after evening meal or before bedtime",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Dosage adjustment in the elderly:",
"     </b>",
"     Decrease dose and/or interval according to physiologic function",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Dosage adjustment in the renal/hepatic impairment:",
"     </b>",
"     Decreased dose and/or interval may be required",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821099\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F3466551\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Tablet: 5 mg, 10 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10493 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0505-217.16.9.173-04C97D187A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13553=[""].join("\n");
var outline_f13_15_13553=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4302636\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3902771\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3466548\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3466550\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821099\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3466551\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10493\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10493|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_15_13554="Mitten deformity";
var content_f13_15_13554=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F86598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F86598&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pseudosyndactyly (mitten deformity) in severe generalized recessive dystrophic epidermolysis bullosa",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 345px; height: 455px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Pseudosyndactyly (mitten deformity) of hands (top) and feet (bottom) with skin atrophy, loss of nails (anonychia), shortening of distal phalanges, and severe contractures in severe generalized recessive dystrophic EB.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Dedee F Murrell, MD, Johann Bauer, MD, and Martin Laimer, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13554=[""].join("\n");
var outline_f13_15_13554=null;
var title_f13_15_13555="Patient information: Spina bifida (myelomeningocele) (The Basics)";
var content_f13_15_13555=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/87049\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/20/7495\">",
"         Pregnancy terms",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/31/15859\">",
"          Amniocentesis",
"         </a>",
"         <li>",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/28/20932\">",
"           Hydrocephalus treated with a shunt",
"          </a>",
"         </li>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?29/11/29874\">",
"         Patient information: Abortion (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/21/16723\">",
"         Patient information: C-section (cesarean delivery) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?30/5/30802\">",
"         Patient information: Epilepsy and pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/1/37907\">",
"         Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?40/59/41906\">",
"         Patient information: Nutrition before and during pregnancy (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/29/37331\">",
"         Patient information: Prenatal care (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?41/47/42739\">",
"         Patient information: Abortion (pregnancy termination) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/45/11988\">",
"         Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Spina bifida (myelomeningocele) (The Basics)",
"    </div>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H262766539\">",
"      <span class=\"h1\">",
"       What is spina bifida?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Spina bifida is a birth defect that involves the spine (backbone). The spine doesn&rsquo;t form normally when the baby develops in the mother&rsquo;s uterus (womb) (",
"      <a class=\"graphic graphic_figure graphicRef82935 \" href=\"UTD.htm?7/20/7495\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      Spina bifida is a type of birth defect called a neural tube defect. There are different kinds of neural tube defects and different forms of spina bifida. This article discusses the most serious form of spina bifida, which is also called &ldquo;open spina bifida&rdquo; or &ldquo;myelomeningocele.&rdquo;",
"     </p>",
"     <p>",
"      When babies have spina bifida, the bones of the spine don&rsquo;t form normally. As a result, these babies have an opening in their skin in the middle or lower part of the back. The spinal cord (the bundle of nerves that run down the back) and the covering around the spinal cord stick out of the opening.",
"     </p>",
"     <p>",
"      Spina bifida leads to different problems. The exact problems will depend on your child&rsquo;s individual situation. But in general, spina bifida can cause:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Weakness of the legs, or being unable to move the legs",
"       </li>",
"       <li>",
"        Loss of feeling in the legs or lower half of the body",
"       </li>",
"       <li>",
"        Problems with the feet, knees, hips, legs, or spine",
"       </li>",
"       <li>",
"        Problems controlling the bladder or bowel",
"       </li>",
"       <li>",
"        Problems with learning, attention, or memory",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Most children with spina bifida also have a condition called hydrocephalus, which is when there is too much spinal fluid in the brain. Spinal fluid is the fluid that surrounds and protects the brain and spinal cord. Hydrocephalus can make a baby&rsquo;s head get bigger over a short period of time.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H262766571\">",
"      <span class=\"h1\">",
"       What causes spina bifida?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Doctors don&rsquo;t usually know what causes spina bifida. But they do know that spina bifida can happen when a pregnant woman doesn&rsquo;t get enough",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?24/57/25492?source=see_link\">",
"       folic acid",
"      </a>",
"      during pregnancy. Folic acid (also called folate) is a vitamin needed for the baby&rsquo;s spine and other parts of the body to develop normally.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H262766586\">",
"      <span class=\"h1\">",
"       Is there a test for spina bifida?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. In the fourth month of pregnancy, women can have a blood test that checks how likely it is that their baby has spina bifida. If this test shows it&rsquo;s likely their baby has spina bifida, the doctor will order a test called an ultrasound. An ultrasound uses sound waves to check how a baby is growing and how his or her organs are developing. It can show whether a baby has spina bifida. Some women have an ultrasound without having the blood test.",
"     </p>",
"     <p>",
"      Sometimes, doctors also do a test called amniocentesis. During this test, a doctor uses a thin needle to remove a small amount of amniotic fluid (the fluid surrounding the baby in the mother&rsquo;s uterus) from a pregnant woman&rsquo;s belly (",
"      <a class=\"graphic graphic_figure graphicRef53857 \" href=\"UTD.htm?15/31/15859\">",
"       figure 2",
"      </a>",
"      ). Tests on the fluid can show whether a baby has spina bifida.",
"     </p>",
"     <p>",
"      After birth, a doctor or midwife can tell whether a baby has spina bifida by doing an exam.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H262766618\">",
"      <span class=\"h1\">",
"       How is spina bifida treated during pregnancy?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Spina bifida is not treated during pregnancy.",
"     </p>",
"     <p>",
"      Some women who find out their baby has spina bifida might choose to end their pregnancy. Women who choose to continue their pregnancy should make sure to deliver their baby in a hospital or center that has experience treating babies with spina bifida.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H262766633\">",
"      <span class=\"h1\">",
"       How is spina bifida treated after birth?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Soon after birth, your baby will need surgery to close the opening in his or her back. Until the surgery can be done, the doctor will keep this open area covered and protected. He or she will also give your baby antibiotics to prevent an infection.",
"     </p>",
"     <p>",
"      Babies with spina bifida are checked for hydrocephalus. To check for hydrocephalus, the doctor will order an ultrasound of your baby&rsquo;s head. The doctor or nurse will also measure the size of your baby&rsquo;s head every few days.",
"     </p>",
"     <p>",
"      Babies who have hydrocephalus are usually treated with a device called a shunt (",
"      <a class=\"graphic graphic_figure graphicRef83273 \" href=\"UTD.htm?20/28/20932\">",
"       figure 3",
"      </a>",
"      ). A shunt is a long tube that goes in the fluid-filled space in the brain. The tube is placed under the skin and empties into the belly or heart. It helps drain extra spinal fluid from the brain.",
"     </p>",
"     <p>",
"      Other treatments will depend on the problems your child has from his or her spina bifida. Treatment for spina bifida is life-long. Many children with spina bifida:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Use a wheelchair or wear leg braces to help them walk",
"       </li>",
"       <li>",
"        Use a tube called a catheter to help them empty their bladder, if their bladder doesn&rsquo;t work normally &ndash; This helps prevent infections and kidney damage.",
"       </li>",
"       <li>",
"        Have surgery to fix problems with their spine or legs",
"       </li>",
"       <li>",
"        Have testing to check whether they have learning problems &ndash; Some children with learning problems need a special learning plan for school.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H262766665\">",
"      <span class=\"h1\">",
"       Can spina bifida be prevented?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Getting enough",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?24/57/25492?source=see_link\">",
"       folic acid",
"      </a>",
"      during pregnancy can prevent some cases of spina bifida. To help prevent spina bifida, a woman should start taking a daily multivitamin with folic acid or prenatal vitamin",
"      <strong>",
"       before",
"      </strong>",
"      she gets pregnant. That&rsquo;s because by the time a woman finds out she is pregnant, her baby&rsquo;s spine and nervous system have already started to develop.",
"     </p>",
"     <p>",
"      Women who take medicines called anti-seizure medicines might need extra",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?24/57/25492?source=see_link\">",
"       folic acid",
"      </a>",
"      . That&rsquo;s because anti-seizure medicines can lower the amount of folic acid in the body.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H262766680\">",
"      <span class=\"h1\">",
"       What will my child's life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It depends on your child&rsquo;s individual situation. Children who are born with spina bifida are healthier and living longer today than they did only a few decades ago.",
"     </p>",
"     <p>",
"      To help your child stay as healthy as possible, it&rsquo;s important to work closely with his or her team of doctors, nurses, and other professionals. Follow their instructions about visits, tests, and treatments. Let them know if you see any changes in your child&rsquo;s symptoms or health. These could be caused by problems from the spina bifida and need treatment.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H262766695\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?37/1/37907?source=see_link\">",
"       Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/29/37331?source=see_link\">",
"       Patient information: Prenatal care (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41906?source=see_link\">",
"       Patient information: Nutrition before and during pregnancy (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/21/16723?source=see_link\">",
"       Patient information: C-section (cesarean delivery) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/11/29874?source=see_link\">",
"       Patient information: Abortion (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?30/5/30802?source=see_link\">",
"       Patient information: Epilepsy and pregnancy (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?11/45/11988?source=see_link\">",
"       Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?41/47/42739?source=see_link\">",
"       Patient information: Abortion (pregnancy termination) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?13/15/13555?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 87049 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-61.234.146.186-49B032D4AE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13555=[""].join("\n");
var outline_f13_15_13555=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766539\">",
"      What is spina bifida?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766571\">",
"      What causes spina bifida?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766586\">",
"      Is there a test for spina bifida?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766618\">",
"      How is spina bifida treated during pregnancy?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766633\">",
"      How is spina bifida treated after birth?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766665\">",
"      Can spina bifida be prevented?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766680\">",
"      What will my child's life be like?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H262766695\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/87049\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?7/20/7495\">",
"      Pregnancy terms",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/31/15859\">",
"       Amniocentesis",
"      </a>",
"      <li>",
"       <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/28/20932\">",
"        Hydrocephalus treated with a shunt",
"       </a>",
"      </li>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/11/29874?source=related_link\">",
"      Patient information: Abortion (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?41/47/42739?source=related_link\">",
"      Patient information: Abortion (pregnancy termination) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?11/45/11988?source=related_link\">",
"      Patient information: C-section (cesarean delivery) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/21/16723?source=related_link\">",
"      Patient information: C-section (cesarean delivery) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?30/5/30802?source=related_link\">",
"      Patient information: Epilepsy and pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?37/1/37907?source=related_link\">",
"      Patient information: How to plan and prepare for a healthy pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41906?source=related_link\">",
"      Patient information: Nutrition before and during pregnancy (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/29/37331?source=related_link\">",
"      Patient information: Prenatal care (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_15_13556="Multifocal cutaneous lesions";
var content_f13_15_13556=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56900&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Multifocal cutaneous lesions",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 320px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: da Rosa, AC, Scroferneker, ML, Vettorato, R, et al. Epidemiology of sporotrichosis: a study of 304 cases in Brazil. J Am Acad Dermatol 2005; 52:451. Copyright &copy; 2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13556=[""].join("\n");
var outline_f13_15_13556=null;
var title_f13_15_13557="Tetrabenazine: Patient drug information";
var content_f13_15_13557=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Tetrabenazine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=see_link\">",
"     see \"Tetrabenazine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6458845\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Xenazine&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F855068\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Nitoman&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10028971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700557",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Children and teens who take this drug may be at a greater risk of having thoughts or actions of suicide. Adults may also be at risk. The risk may be greater in people who have had these thoughts or actions in the past. Watch people who take this drug closely. Call the doctor right away if signs like low mood (depression), nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10028973\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower or stop repeated actions that are not of any use and are not caused by you.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10028972\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703009",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to tetrabenazine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703859",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have taken certain drugs used for low mood (depression) like isocarboxazid, phenelzine, or tranylcypromine or drugs used for Parkinson's disease like selegiline or rasagiline in the last 14 days. Taking this drug within 14 days of those drugs can cause very bad high blood pressure. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705213",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Low mood (depression), thoughts of taking your own life, or liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10028977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697190",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have breast cancer, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697133",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a fast heartbeat, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697306",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have mental illness or thoughts of taking your own life, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697320",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have Parkinson's disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698421",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10028978\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698039",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Extra muscle action or slow movement.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697997",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low mood (depression).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698279",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Nervous and excitable.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698162",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to sleep.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10028980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699075",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low mood (depression), thoughts of killing yourself, nervousness, emotional ups and downs, thinking that is not normal, anxiety, or lack of interest in life.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698644",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble swallowing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699055",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shakiness, trouble moving around, or stiffness.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3448683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have missed more than 5 days of taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10028975\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10028976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10028981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10028982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11447 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-27.109.116.13-23EAA62341-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13557=[""].join("\n");
var outline_f13_15_13557=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6458845\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F855068\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028971\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028973\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028972\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028977\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028978\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028980\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028975\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028976\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028981\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10028982\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?31/31/32246?source=related_link\">",
"      Tetrabenazine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_15_13558="Ichthyosis vulgaris 3";
var content_f13_15_13558=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68882&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ichthyosis vulgaris, sparing of flexural areas",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Ichthyosis vulgaris. This patient has atopic dermatitis and ichthyosis vulgaris lesions that resemble fish scales. Note the characteristic sparing of the popliteal fossa.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Goodheart HP. Goodheart's Photoguide of Common Skin Disorders, 2nd Edition, Lippincott Williams &amp; Wilkins, Philadelphia 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13558=[""].join("\n");
var outline_f13_15_13558=null;
var title_f13_15_13559="Treatment of vertigo";
var content_f13_15_13559=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Treatment of vertigo",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Joseph M Furman, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Jason JS Barton, MD, PhD, FRCPC",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Daniel G Deschler, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13559/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/15/13559/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 9, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities of the vestibular system often result in vertigo, which is associated with significant disability, including loss of work time and interruption of daily activities [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/1\">",
"     1",
"    </a>",
"    ]. Vestibular vertigo may arise from peripheral lesions (eg, labyrinth or vestibular nerve) or central lesions (eg, brainstem or cerebellum). Appropriate management of vertigo requires the correct diagnosis. This includes identifying the origin of dizziness as a problem with the vestibular system and then determining the site and origin of that problem.",
"   </p>",
"   <p>",
"    This topic will review the management of the patient with vertigo. Distinguishing vertigo from other types of dizziness, determining the cause of vertigo, and the differential diagnosis of vertigo are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23223?source=see_link\">",
"     \"Approach to the patient with dizziness\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=see_link\">",
"     \"Approach to the patient with vertigo\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=see_link\">",
"     \"Benign paroxysmal positional vertigo\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Vertigo treatment can be divided into three categories: those specific to the underlying vestibular disease, those aimed at alleviating the symptoms of vertigo, and those aimed at promoting recovery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     DISEASE SPECIFIC TREATMENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertigo is caused by a number of conditions affecting either the peripheral vestibular apparatus in the inner ear or the central nervous system (",
"    <a class=\"graphic graphic_table graphicRef66539 \" href=\"UTD.htm?24/29/25051\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17001?source=see_link\">",
"     \"Pathophysiology, etiology, and differential diagnosis of vertigo\"",
"    </a>",
"    .) In some cases, treatment of the underlying condition improves vertigo. In others, treatment does not improve symptoms but may be otherwise important for the patient's overall prognosis.",
"   </p>",
"   <p>",
"    Treatment of the underlying disease may diminish the symptoms of vertigo or alter the disease course in the following conditions:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vestibular neuritis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35062?source=see_link\">",
"       \"Vestibular neuritis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Benign paroxysmal positional vertigo (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=see_link\">",
"       \"Benign paroxysmal positional vertigo\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Cogan's syndrome (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/42/12968?source=see_link\">",
"       \"Cogan&rsquo;s syndrome\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Herpes zoster (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=see_link&amp;anchor=H15#H15\">",
"       \"Clinical manifestations of varicella-zoster virus infection: Herpes zoster\", section on 'Ramsay Hunt syndrome (Herpes zoster oticus)'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33096?source=see_link\">",
"       \"Treatment of herpes zoster in the immunocompetent host\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Meniere disease (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/61/32729?source=see_link\">",
"       \"Meniere disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Perilymphatic fistula (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17001?source=see_link&amp;anchor=H10#H10\">",
"       \"Pathophysiology, etiology, and differential diagnosis of vertigo\", section on 'Perilymphatic fistula'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Superior canal dehiscence (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17001?source=see_link&amp;anchor=H11#H11\">",
"       \"Pathophysiology, etiology, and differential diagnosis of vertigo\", section on 'Semicircular canal dehiscence syndrome'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Episodic ataxia type 2 (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37433?source=see_link&amp;anchor=H19#H19\">",
"       \"Overview of the hereditary ataxias\", section on 'Episodic ataxias'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Migrainous vertigo (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15496?source=see_link\">",
"       \"Migrainous vertigo\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Multiple sclerosis (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41082?source=see_link\">",
"       \"Treatment of relapsing-remitting multiple sclerosis in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26265?source=see_link\">",
"       \"Treatment of progressive multiple sclerosis in adults\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Vertebrobasilar ischemia (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/33/32281?source=see_link&amp;anchor=H2#H2\">",
"       \"Secondary prevention for specific causes of ischemic stroke and transient ischemic attack\", section on 'Large vessel disease'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Vestibular schwannoma (acoustic neuroma) (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40232?source=see_link\">",
"       \"Vestibular schwannoma (acoustic neuroma)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     SYMPTOMATIC TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Medications to suppress vestibular symptoms are best used for alleviating acute episodes of vertigo that last at least a few hours or days. These drugs are not useful for very brief vertigo, such as benign paroxysmal positional vertigo, except when the frequency of spells is very high.",
"   </p>",
"   <p>",
"    Three general classes of drugs can be used to suppress the vestibular system (",
"    <a class=\"graphic graphic_table graphicRef68052 \" href=\"UTD.htm?25/16/25868\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antihistamines &mdash;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/17/37141?source=see_link\">",
"       meclizine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?11/46/12006?source=see_link\">",
"       dimenhydrinate",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/2/33824?source=see_link\">",
"       diphenhydramine",
"      </a>",
"     </li>",
"     <li>",
"      Phenothiazine antiemetics &mdash;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?22/28/22984?source=see_link\">",
"       prochlorperazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/20/15688?source=see_link\">",
"       promethazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"       metoclopramide",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"       domperidone",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?21/2/21544?source=see_link\">",
"       ondansetron",
"      </a>",
"     </li>",
"     <li>",
"      Benzodiazepines &mdash;",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"       lorazepam",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/45/26328?source=see_link\">",
"       clonazepam",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?30/31/31224?source=see_link\">",
"       alprazolam",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Responses are generally dose related. These medications are effective in ameliorating vertigo, especially in the acute setting, when concern for side effects is not paramount.",
"   </p>",
"   <p>",
"    The antihistamines are the drugs of choice in most patients. The phenothiazine antiemetics are more sedating and usually reserved for patients with severe vomiting. Benzodiazepines are also sedating and are typically given to patients with contraindications to anticholinergics, such as prostatism and glaucoma.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/17/37141?source=see_link\">",
"     Meclizine",
"    </a>",
"    is the drug of choice in pregnancy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Side effects are often minimal other than sedation. Extrapyramidal symptoms are a risk with phenothiazine antiemetics and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?0/13/216?source=see_link\">",
"     metoclopramide",
"    </a>",
"    but less so with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/43/1717?source=see_link\">",
"     domperidone",
"    </a>",
"    , a peripheral dopaminergic antagonist that does not cross the blood brain barrier. Anticholinergic agents can cause urinary retention and dry mouth.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/31/33264?source=see_link\">",
"     Scopolamine",
"    </a>",
"    withdrawal can lead to worsening of dizziness.",
"   </p>",
"   <p>",
"    A homeopathic remedy, \"vertigoheel,\" had equivalent benefit to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?16/42/17059?source=see_link\">",
"     betahistine",
"    </a>",
"    in one randomized, double-blind, controlled study of 119 patients with vertigo of various etiologies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/4\">",
"     4",
"    </a>",
"    ]. This observation was supported by the results of a meta-analysis comparing vertigoheel with betahistine and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/46/12006?source=see_link\">",
"     dimenhydrinate",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These drugs should be stopped as soon as possible after vomiting ceases (usually within one or two days) to avoid compromising long-term adaptation to vestibular loss by the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/6\">",
"     6",
"    </a>",
"    ]. A number of studies in animal models have shown that these medications are associated with impaired central compensation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     VESTIBULAR REHABILITATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Studies in humans and animal models have shown that clinical recovery after peripheral vestibular injury occurs in advance of improved peripheral vestibular function, suggesting that most of the early recovery and a substantial portion of the total recovery derives from central nervous system compensation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/7-10\">",
"     7-10",
"    </a>",
"    ]. This central compensation appears to be multisensory in its scope and is the primary target of vestibular rehabilitation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/11\">",
"     11",
"    </a>",
"    ]. There is some evidence that early rehabilitation is more effective than late intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/12,13\">",
"     12,13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Vestibular rehabilitation (physical therapy) promotes recovery in patients with permanent unilateral or bilateral peripheral vestibular hypofunction [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/12,14\">",
"     12,14",
"    </a>",
"    ]. It is not known whether vestibular rehabilitation is useful for central vestibular disorders, although preliminary evidence suggests that it might have benefit [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/15\">",
"     15",
"    </a>",
"    ]. Referral can be arranged through most physiotherapy departments or dizzy clinics.",
"   </p>",
"   <p>",
"    Most patients with vertigo prefer to lie with their head still. Vestibular rehabilitation forces them to perform challenging balance exercises with several potential benefits:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Activity promotes adaptation &mdash; The brain can readjust or adapt its responses to take into account reduced vestibular input, particularly if one side is still normal. This is optimally accomplished when the brain has experience with vision during head motion, to determine how much error the lesion has introduced [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/16\">",
"       16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Activity facilitates strategic substitution &mdash; There are other means of reducing spatial uncertainty, even if the vestibular system cannot recover. The cervico-ocular reflex can increase its input, and other eye movements can help stabilize gaze [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/17\">",
"       17",
"      </a>",
"      ]. Alternative spatial cues from vision and proprioception can improve balance and walking.",
"     </li>",
"     <li>",
"      Inactivity has secondary negative effects &mdash; Patients become physically deconditioned, which exacerbates the inadequacy of their postural reflexes. They also become psychologically deconditioned, sometimes to the point where \"phobic postural vertigo\" becomes the greatest obstacle to their recovery [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/18\">",
"       18",
"      </a>",
"      ]. Fear of falling is particularly problematic in the elderly after a vestibular event, and it can limit mobility indefinitely without a rehabilitation program [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/19\">",
"       19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Vestibular exercises have been used for 60 years [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/20,21\">",
"     20,21",
"    </a>",
"    ]. However, they have only more recently been studied in randomized, controlled trials. Limitations of these studies include that they are unblinded with short-term follow-up.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <strong>",
"       Acute peripheral vertigo",
"      </strong>",
"      &mdash; The exercises commonly provided for persons with acute vestibular events include focusing on an object with a blank background and moving the head slowly to the right and left. The exercise is done is the pitch",
"      <span class=\"nowrap\">",
"       (up/down)",
"      </span>",
"      and yaw",
"      <span class=\"nowrap\">",
"       (left/right)",
"      </span>",
"      plane. Shortly after a vestibular injury the patient is encouraged to move his or her head slowly to avoid severe nausea. Then the speed is increased as the patient tolerates. Most patients are asked to perform these exercises two to three times each day for several minutes.",
"      <br/>",
"      <br/>",
"      Two trials have shown that vestibular exercises begun shortly after the onset of acute unilateral vestibular hypofunction due to vestibular neuritis or vestibular surgery significantly improve balance at one month [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/22,23\">",
"       22,23",
"      </a>",
"      ]. It is not known whether the improvements persist beyond one month.",
"     </li>",
"     <li>",
"      <strong>",
"       Chronic peripheral vertigo",
"      </strong>",
"      &mdash; The exercises recommended for persons with chronic peripheral vertigo are generally much more aggressive than those for persons with acute disorders. Patients are asked to perform eye and head movements while standing, walking forward, walking backward, and while standing or walking on compliant or uneven surfaces. The focus of the program is to perform increasingly more difficult postural tasks with increasingly more eye and head movements while keeping symptoms manageable.",
"      <br/>",
"      <br/>",
"      A study of patients with chronic dizziness for at least six months duration due to unilateral peripheral vestibular dysfunction found that dizziness improved with either vestibular therapy or drugs, but improved balance occurred only in the group receiving physical therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/24\">",
"       24",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Treatment with home exercises may be as effective as supervised outpatient therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]. Two randomized controlled trials of patients with chronic peripheral vestibular disorders in general practice evaluated a standard home vestibular program [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/25,26\">",
"       25,26",
"      </a>",
"      ]. Treated patients had significant improvement on all primary outcome measures (dizziness, dizziness-related quality of life, and postural stability) compared with the control groups at three and six months of follow-up [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/12\">",
"       12",
"      </a>",
"      ]. A limitation of these studies is that participants could not be blinded to treatment status.",
"     </li>",
"     <li>",
"      <strong>",
"       Bilateral vestibular injury",
"      </strong>",
"      &mdash; Complete bilateral loss of vestibular function eliminates the possibility of adaptation, and patients often do not improve [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/28\">",
"       28",
"      </a>",
"      ]. Nevertheless, exercises may promote strategic substitutions [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/29\">",
"       29",
"      </a>",
"      ]. Saccadic eye exercises and exercises that attempt to optimize the efficacy of neck stretch receptors are emphasized in persons with bilateral vestibular loss. If there is a possibility that the patient has any remaining vestibular function, a trial of vestibuloocular exercises is initiated as well.",
"      <br/>",
"      <br/>",
"      Education about fall prevention is critical for persons with bilateral loss, as they have a particularly high fall risk [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/30\">",
"       30",
"      </a>",
"      ]. Darkness and uneven surfaces will provide additional challenges for these patients.",
"      <br/>",
"      <br/>",
"      A double-blind, placebo-controlled study found that physical therapy improved balance and gait speed in eight patients with bilateral vestibular injury, despite continued impairment of vestibular function [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <strong>",
"       Central vertigo",
"      </strong>",
"      &mdash; Persons with central vestibular loss often have constant symptoms. Gait and balance activities are emphasized along with eye and head movements. Most patients are instructed to perform these exercises two to three times per week. Nausea may be limiting; the use of medications in conjunction with physical therapy may improve participation and final outcome [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/32\">",
"       32",
"      </a>",
"      ]. Adaptive methods to perform functional activities are often taught. Persons with central vestibular disorders take longer to improve than those with peripheral vestibular dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. For central disorders, only observational, uncontrolled reports are available to support the use of vestibular rehabilitation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, most agree that vestibular exercises can improve dizziness and postural confidence in the short term. Ideally, exercise regimens should begin immediately after symptom onset because of evidence of a critical period of adaptation and compensation that are seen in animal studies [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13559/abstract/7,36\">",
"     7,36",
"    </a>",
"    ]. We refer our patients to therapists trained in vestibular rehabilitation to develop customized exercise programs.",
"   </p>",
"   <p>",
"    Further studies are needed to determine whether the gains obtained from vestibular rehabilitation are maintained in the long term, and whether such long-term gains are significant and relevant in regard to decreasing the risk of falls, improving gait, and promoting normal lifestyles.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41905?source=see_link\">",
"       \"Patient information: Vertigo (a type of dizziness) (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?40/31/41460?source=see_link\">",
"       \"Patient information: Dizziness and vertigo (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vertigo treatment can be divided into three categories: those specific to the underlying vestibular disease, those aimed at the symptom of vertigo, and those aimed at promoting recovery.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Because cause-specific treatments of vertigo can alleviate symptoms and affect short- and long-term prognosis, accurate diagnosis of the underlying etiology is an important first step in the treatment of vertigo. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=see_link\">",
"       \"Approach to the patient with vertigo\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17001?source=see_link\">",
"       \"Pathophysiology, etiology, and differential diagnosis of vertigo\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      A variety of symptomatic treatments provide relief to acute symptoms (",
"      <a class=\"graphic graphic_table graphicRef68052 \" href=\"UTD.htm?25/16/25868\">",
"       table 2",
"      </a>",
"      ). Doses should be started low and increased to positive effect or side effect. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Symptomatic treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest stopping acute symptomatic treatments within 48 hours if the patient&rsquo;s symptoms allow (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Some data suggest that these medications interfere with central compensation and long-term recovery.",
"     </li>",
"     <li>",
"      We recommend vestibular exercises in patients with peripheral vestibular disorders to promote early recovery (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). Vestibular rehabilitation may be accomplished by a series of sessions with a physical therapist, or the patient may be trained to do these independently, at home. Some data suggest that early initiation of these treatments may maximize benefit. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Vestibular rehabilitation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest a trial of vestibular therapy in patients with central vestibular disorders (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). There is little data regarding the benefit of therapy in these patients, but few other treatment options exist. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Vestibular rehabilitation'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/1\">",
"      Neuhauser HK, Radtke A, von Brevern M, et al. Burden of dizziness and vertigo in the community. Arch Intern Med 2008; 168:2118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/2\">",
"      Mitchelson F. Pharmacological agents affecting emesis. A review (Part I). Drugs 1992; 43:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/3\">",
"      Leatham AM. Safety and efficacy of anti-emetics used to treat nausea and vomiting in pregnancy. Clin Pharmacol 1986; 5:660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/4\">",
"      Weiser M, Str&ouml;sser W, Klein P. Homeopathic vs conventional treatment of vertigo: a randomized double-blind controlled clinical study. Arch Otolaryngol Head Neck Surg 1998; 124:879.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/5\">",
"      Schneider B, Klein P, Weiser M. Treatment of vertigo with a homeopathic complex remedy compared with usual treatments: a meta-analysis of clinical trials. Arzneimittelforschung 2005; 55:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/6\">",
"      Baloh RW. Clinical practice. Vestibular neuritis. N Engl J Med 2003; 348:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/7\">",
"      Strupp M, Arbusow V, Brandt T. Exercise and drug therapy alter recovery from labyrinth lesion in humans. Ann N Y Acad Sci 2001; 942:79.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/8\">",
"      Dieterich M, Brandt T. Functional brain imaging of peripheral and central vestibular disorders. Brain 2008; 131:2538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/9\">",
"      zu Eulenburg P, Stoeter P, Dieterich M. Voxel-based morphometry depicts central compensation after vestibular neuritis. Ann Neurol 2010; 68:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/10\">",
"      Parietti-Winkler C, Gauchard GC, Simon C, Perrin PP. Long-term effects of vestibular compensation on balance control and sensory organisation after unilateral deafferentation due to vestibular schwannoma surgery. J Neurol Neurosurg Psychiatry 2010; 81:934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/11\">",
"      Helmchen C, Klinkenstein JC, Kr&uuml;ger A, et al. Structural brain changes following peripheral vestibulo-cochlear lesion may indicate multisensory compensation. J Neurol Neurosurg Psychiatry 2011; 82:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/12\">",
"      Hillier SL, Hollohan V. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database Syst Rev 2007; :CD005397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/13\">",
"      Bamiou DE, Davies RA, McKee M, Luxon LM. Symptoms, disability and handicap in unilateral peripheral vestibular disorders. Effects of early presentation and initiation of balance exercises. Scand Audiol 2000; 29:238.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/14\">",
"      Vereeck L, Wuyts FL, Truijen S, et al. The effect of early customized vestibular rehabilitation on balance after acoustic neuroma resection. Clin Rehabil 2008; 22:698.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/15\">",
"      Gurr B, Moffat N. Psychological consequences of vertigo and the effectiveness of vestibular rehabilitation for brain injury patients. Brain Inj 2001; 15:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/16\">",
"      Mathog RH, Peppard SB. Exercise and recovery from vestibular injury. Am J Otolaryngol 1982; 3:397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/17\">",
"      Schubert MC, Minor LB. Vestibulo-ocular physiology underlying vestibular hypofunction. Phys Ther 2004; 84:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/18\">",
"      Brandt T. Phobic postural vertigo. Neurology 1996; 46:1515.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/19\">",
"      Salles N, Kressig RW, Michel JP. Management of chronic dizziness in elderly people. Z Gerontol Geriatr 2003; 36:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/20\">",
"      Cawthorne T. The physiological basis for head exercises. J Chart Soc Physiother 1944; 30:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/21\">",
"      Cooksey FS. Rehabilitation in vestibular injuries. Proc Soc Med 1945; 39:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/22\">",
"      Strupp M, Arbusow V, Maag KP, et al. Vestibular exercises improve central vestibulospinal compensation after vestibular neuritis. Neurology 1998; 51:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/23\">",
"      Herdman SJ, Clendaniel RA, Mattox DE, et al. Vestibular adaptation exercises and recovery: acute stage after acoustic neuroma resection. Otolaryngol Head Neck Surg 1995; 113:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/24\">",
"      Horak FB, Jones-Rycewicz C, Black FO, Shumway-Cook A. Effects of vestibular rehabilitation on dizziness and imbalance. Otolaryngol Head Neck Surg 1992; 106:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/25\">",
"      Yardley L, Beech S, Zander L, et al. A randomized controlled trial of exercise therapy for dizziness and vertigo in primary care. Br J Gen Pract 1998; 48:1136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/26\">",
"      Yardley L, Donovan-Hall M, Smith HE, et al. Effectiveness of primary care-based vestibular rehabilitation for chronic dizziness. Ann Intern Med 2004; 141:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/27\">",
"      Kammerlind AS, Ledin TE, Odkvist LM, Skargren EI. Effects of home training and additional physical therapy on recovery after acute unilateral vestibular loss--a randomized study. Clin Rehabil 2005; 19:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/28\">",
"      Zingler VC, Weintz E, Jahn K, et al. Follow-up of vestibular function in bilateral vestibulopathy. J Neurol Neurosurg Psychiatry 2008; 79:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/29\">",
"      Gillespie MB, Minor LB. Prognosis in bilateral vestibular hypofunction. Laryngoscope 1999; 109:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/30\">",
"      Herdman SJ, Blatt P, Schubert MC, Tusa RJ. Falls in patients with vestibular deficits. Am J Otol 2000; 21:847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/31\">",
"      Krebs DE, Gill-Body KM, Riley PO, Parker SW. Double-blind, placebo-controlled trial of rehabilitation for bilateral vestibular hypofunction: preliminary report. Otolaryngol Head Neck Surg 1993; 109:735.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/32\">",
"      Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998; 108:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/33\">",
"      Shepard NT, Telian SA, Smith-Wheelock M, Raj A. Vestibular and balance rehabilitation therapy. Ann Otol Rhinol Laryngol 1993; 102:198.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/34\">",
"      Shepard NT, Telian SA. Programmatic vestibular rehabilitation. Otolaryngol Head Neck Surg 1995; 112:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/35\">",
"      Brown KE, Whitney SL, Marchetti GF, et al. Physical therapy for central vestibular dysfunction. Arch Phys Med Rehabil 2006; 87:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13559/abstract/36\">",
"      Dieterich M. Easy, inexpensive, and effective: vestibular exercises for balance control. Ann Intern Med 2004; 141:641.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5097 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.55.141.10-E570A510C7-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13559=[""].join("\n");
var outline_f13_15_13559=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H5\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      DISEASE SPECIFIC TREATMENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      SYMPTOMATIC TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      VESTIBULAR REHABILITATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5097\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5097|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/29/25051\" title=\"table 1\">",
"      Causes of vertigo",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?25/16/25868\" title=\"table 2\">",
"      Drugs for acute vertigo",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/43/23223?source=related_link\">",
"      Approach to the patient with dizziness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/19/32057?source=related_link\">",
"      Approach to the patient with vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/13/19673?source=related_link\">",
"      Benign paroxysmal positional vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/20/2378?source=related_link\">",
"      Clinical manifestations of varicella-zoster virus infection: Herpes zoster",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/42/12968?source=related_link\">",
"      Cogan&rsquo;s syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/61/32729?source=related_link\">",
"      Meniere disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/8/15496?source=related_link\">",
"      Migrainous vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/35/37433?source=related_link\">",
"      Overview of the hereditary ataxias",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/38/17001?source=related_link\">",
"      Pathophysiology, etiology, and differential diagnosis of vertigo",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?40/31/41460?source=related_link\">",
"      Patient information: Dizziness and vertigo (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?40/59/41905?source=related_link\">",
"      Patient information: Vertigo (a type of dizziness) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/33/32281?source=related_link\">",
"      Secondary prevention for specific causes of ischemic stroke and transient ischemic attack",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/20/33096?source=related_link\">",
"      Treatment of herpes zoster in the immunocompetent host",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/41/26265?source=related_link\">",
"      Treatment of progressive multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/7/41082?source=related_link\">",
"      Treatment of relapsing-remitting multiple sclerosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/15/35062?source=related_link\">",
"      Vestibular neuritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/18/40232?source=related_link\">",
"      Vestibular schwannoma (acoustic neuroma)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_15_13560="Surgical resection of pulmonary metastases: Outcomes by histology";
var content_f13_15_13560=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"6\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Surgical resection of pulmonary metastases: Outcomes by histology",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13560/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13560/contributors\">",
"     Michael T Jaklitsch, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13560/contributors\">",
"     James R Jett, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13560/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13560/contributors\">",
"     Reed E Drews, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13560/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13560/contributors\">",
"     Diane MF Savarese, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/15/13560/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 21, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Lung metastases from a primary extrapulmonary malignancy are often a manifestation of widespread dissemination; however, some patients have no other evidence of disease [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/1\">",
"     1",
"    </a>",
"    ]. Extensive experience with pulmonary metastasectomy in a number of different cancers has confirmed that resection is associated with prolonged relapse-free survival and cure in some patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/2\">",
"     2",
"    </a>",
"    ]. Based upon these observations, aggressive resection of isolated pulmonary metastases has become a widely accepted treatment for appropriately selected patients. However, a survival benefit from pulmonary metastasectomy has never been shown in a randomized trial for any histologic subtype, and questions remain as to whether it is the resection or simply selection of patients with a more favorable natural history that is responsible for the apparent improvement in survival associated with metastasectomy. &nbsp;",
"   </p>",
"   <p>",
"    Data from the International Registry of Lung Metastases showed that the survival rates at 5, 10, and 15 years following complete resection in a variety of histologic tumor types were 36, 26, and 22 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/3\">",
"     3",
"    </a>",
"    ]. The survival rate is influenced by the disease-free interval, number of metastases, extent of resection. The potential benefits of resection and the approach to the patient are also dependent upon the histology of the tumor [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    This topic review will cover the outcomes of pulmonary metastasectomy in various tumor types, and the use of adjuvant therapy following resection, where indicated. Specific issues related to patients undergoing resection of lung metastases from soft tissue sarcoma, and a general discussion of the benefits of pulmonary metastasectomy, selection criteria, preoperative evaluation and techniques for surgical resection are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44680?source=see_link\">",
"     \"Surgical treatment and other localized therapy for metastatic soft tissue sarcoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The integration of surgery into multidisciplinary therapy for patients with specific malignancies is discussed in the appropriate topic reviews.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SOFT TISSUE SARCOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Soft tissue sarcomas primarily metastasize to the lungs, and surgery is the only potential curative treatment. The role of surgery in the treatment of lung metastases from soft tissue sarcoma is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44680?source=see_link&amp;anchor=H2#H2\">",
"     \"Surgical treatment and other localized therapy for metastatic soft tissue sarcoma\", section on 'Pulmonary metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     COLORECTAL CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The last 10 years have seen marked and impressive improvements in survival for patients with metastatic colorectal cancer, attributed to the availability of several new active drugs. However, five-year survival rates with even the most active regimen (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    and short-term infusional 5-fluorouracil and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"     leucovorin",
"    </a>",
"    , termed FOLFOX) are only 10 percent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=see_link\">",
"     \"Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although randomized trials have not been conducted, encouraging results with surgery in retrospective reports have led to the acceptance of aggressive surgical resection in carefully selected patients with pulmonary metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/4-15\">",
"     4-15",
"    </a>",
"    ]. The overall five- and ten-year survival rates are approximately 35 to 56 percent and 20 to 30 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/4-14\">",
"     4-14",
"    </a>",
"    ]. These rates are higher than those seen with systemic chemotherapy alone.",
"   </p>",
"   <p>",
"    Prognostic factors associated with an improved prognosis following metastasectomy include a limited number of nodules, a normal pre-thoracotomy carcinoembryonic antigen (CEA) level, the absence of regional lymph node spread, metachronous rather than synchronous presentation, and a longer duration between cancer onset and the development of metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/9,11,13,14,16-20\">",
"     9,11,13,14,16-20",
"    </a>",
"    ]. In a series of 378 patients undergoing surgery for pulmonary metastases from colorectal cancer at Memorial Sloan-Kettering, recurrence-free survival was 49 percent at three years for those with a single lesion and a disease-free interval of greater than one year [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/20\">",
"     20",
"    </a>",
"    ]. In contrast, there were no survivors beyond three years among the 44 patients with three or more lesions and a less than one-year disease-free interval.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Significance of synchronous or metachronous liver metastases",
"    </span>",
"    &nbsp;&mdash;&nbsp;The presence of both liver and lung metastases or a history of previously resected hepatic metastases do not necessarily represent a contraindication to pulmonary metastasectomy, as long as a complete resection of all sites of disease can be accomplished. However, outcomes may not be as favorable as compared to those with isolated intrathoracic metastases [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/4,9,21-23\">",
"     4,9,21-23",
"    </a>",
"    ]. This was illustrated in series of 121 patients with colorectal cancer pulmonary metastases reported at the 2009 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancer Symposium [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/9\">",
"     9",
"    </a>",
"    ]. Resection of extrapulmonary metastases had been performed prior to pulmonary metastasectomy in 36 (30 percent). In a preliminary report, the two-year disease-free survival rate was 42 percent overall; it was significantly higher in those without extrapulmonary metastases (49 versus 21 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Benefit of postresection adjuvant therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although there is no high-quality evidence from clinical trials that prove a survival benefit, patients who have undergone resection of the more common isolated colorectal cancer liver metastases are typically given a six month course of combination chemotherapy. A modern,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -based regimen is usually chosen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H19#H19\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Therapy after resection of liver metastases'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The benefit of chemotherapy following resection of lung metastases is incompletely defined. The following data pertain to this issue:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The benefit of adjuvant chemotherapy after a potentially curative resection of either liver (85 percent of study cohort) or lung (less than 10 percent) colorectal cancer metastases was addressed in a meta-analysis of two randomized trials of similar design (both using six months of systemic 5-FU and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/54/24423?source=see_link\">",
"       leucovorin",
"      </a>",
"      chemotherapy) that were initiated in the early 1990s (the French FFCD 9002 and",
"      <span class=\"nowrap\">",
"       EORTC/NCIC",
"      </span>",
"      trials); both were closed prematurely because of slow accrual [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/24\">",
"       24",
"      </a>",
"      ]. In a combined analysis of both trials (totaling 278 patients), the differences in median progression-free survival in chemotherapy-treated versus non-chemotherapy-treated patients (28 versus 19 months, p = 0.058) and overall survival (62 versus 47 months), while potentially meaningful, were not statistically significant [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/25\">",
"       25",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      While these data provide a proof of principle of the benefit of postresection adjuvant chemotherapy in this population (which consisted predominantly of patients with resected liver rather than lung metastases), the chemotherapy used in these trials is considered inferior by modern standards. For patients with unresectable metastatic colorectal cancer, the introduction of newer drugs such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"       irinotecan",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"       bevacizumab",
"      </a>",
"      , and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"       cetuximab",
"      </a>",
"      has been accompanied by a marked improvement in median survival from six to seven months to 20 to 24 months. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=see_link\">",
"       \"Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The only data addressing the benefit of modern chemotherapy regimens following resection of colorectal cancer lung metastases comes from the previously described series of 121 patients reported at the 2009 ASCO GI Cancer Symposium [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/9\">",
"       9",
"      </a>",
"      ]. After pulmonary metastasectomy, 88 patients (73 percent) received chemotherapy while 33 did not. The specific regimen was fluoropyrimidine monotherapy,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      -based chemotherapy, and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"       irinotecan",
"      </a>",
"      -based chemotherapy in 23, 39, and 26 patients, respectively.",
"      <br/>",
"      <br/>",
"      The two-year disease-free survival rate was significantly higher among those who received chemotherapy (52 versus 28 percent), but this is not a valid comparison since one-half of the patients who did not receive chemotherapy did not do so because they progressed within four weeks of surgery. The difference in two-year survival with fluoropyrimidine monotherapy versus an oxaliplatin or irinotecan-based regimen (36 versus 59 and 58 percent, respectively) was not statistically significant.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Guidelines from the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     National Comprehensive Cancer Network (NCCN)",
"    </a>",
"    suggest a six-month perioperative course of chemotherapy in patients undergoing resection of either isolated liver or lung metastases from colorectal cancer. Most experts (including the",
"    <a class=\"external\" href=\"file://www.nccn.org/professionals/physician_gls/f_guidelines.asp\">",
"     NCCN)",
"    </a>",
"    would consider an",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -based regimen such as FOLFOX (",
"    <a class=\"graphic graphic_table graphicRef50132 \" href=\"UTD.htm?16/53/17246\">",
"     table 1",
"    </a>",
"    ) to be the reference regimen for this group of patients if they are treated following resection, given the lack of benefit from an adjuvant",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/41/7834?source=see_link\">",
"     irinotecan",
"    </a>",
"    -containing regimen in patients with resected stage II or III colon cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H20#H20\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Systemic chemotherapy'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link&amp;anchor=H19#H19\">",
"     \"Adjuvant therapy for resected stage III (node-positive) colon cancer\", section on 'Irinotecan'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The role of biologic agents that target the epidermal growth factor receptor (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?9/58/10151?source=see_link\">",
"     cetuximab",
"    </a>",
"    ) and tumor angiogenesis (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/20/2377?source=see_link\">",
"     bevacizumab",
"    </a>",
"    ) after resection of pulmonary metastases from colorectal cancer is undefined. However, given the lack of activity of any of these agents after resection of stage II or III colon cancer, most experts would not add a biologic agent to an",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"     oxaliplatin",
"    </a>",
"    -based chemotherapy regimen after resection of pulmonary metastases. In contrast, if patients are treated in the neoadjuvant setting for liver or lung metastases, the addition of a biologic agent is reasonable. Considerations for patients with lung metastases are similar to those in patients with liver metastases. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link&amp;anchor=H21#H21\">",
"     \"Adjuvant therapy for resected stage III (node-positive) colon cancer\", section on 'Bevacizumab'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=see_link&amp;anchor=H23#H23\">",
"     \"Adjuvant therapy for resected stage III (node-positive) colon cancer\", section on 'Cetuximab'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H5844162#H5844162\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Choice of regimen'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H9#H9\">",
"     \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Conversion therapy for initially unresectable metastases'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     RENAL CELL CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary resection for metastases from renal cell carcinoma is associated with a 20 percent or greater five-year survival [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/26-29\">",
"     26-29",
"    </a>",
"    ]. Larger number and size of metastatic nodules, increasing number of lymph node metastases, shorter disease-free interval, and decreased preoperative forced vital capacity are negative prognostic factors in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21192?source=see_link\">",
"     \"Prognostic factors in patients with renal cell carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22630?source=see_link\">",
"     \"Role of surgery in patients with metastatic renal cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There are no data addressing the benefit of postresection systemic (adjuvant) therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     GERM CELL CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The advent of effective chemotherapy has drastically changed the management of pulmonary metastases for patients with germ cell tumors. Chemotherapy is the primary treatment in this setting. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=see_link\">",
"     \"Initial risk-stratified treatment for advanced testicular germ cell tumors\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Surgical resection is reserved for patients who have normalization of serum tumor markers but radiographic evidence of a residual lesion. Patients with a residual lesion on imaging and a continued elevation of tumor markers after their initial chemotherapy are generally managed with an alternative chemotherapy regimen. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38425?source=see_link&amp;anchor=H14#H14\">",
"     \"Surgical management of advanced testicular germ cell tumors\", section on 'Lung lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     GYNECOLOGIC CANCERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Encouraging results have been reported following resection of pulmonary metastases from gynecologic cancers. In a series of 133 patients, the five-year survival rates in women with squamous cell carcinoma, cervical adenocarcinoma, and endometrial carcinoma were 47, 40, and 76 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/30\">",
"     30",
"    </a>",
"    ]. There are no data addressing the benefit of postresection chemotherapy or hormone therapy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/37/33368?source=see_link\">",
"     \"Management of recurrent or metastatic cervical cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22825?source=see_link\">",
"     \"Treatment of locally advanced, recurrent, or metastatic endometrial cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/49/6938?source=see_link&amp;anchor=H550393653#H550393653\">",
"     \"Invasive cervical adenocarcinoma\", section on 'Surgery for metastatic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The primary management of women with lung metastases from choriocarcinoma is chemotherapy, but surgical resection may be useful in women who are not cured by systemic therapy. The management of lung metastases in this disease is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42234?source=see_link\">",
"     \"Gestational trophoblastic neoplasia: Staging and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MELANOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary metastases from malignant melanoma are associated with poor survival due to the aggressive behavior of this tumor and its propensity to metastasize systemically to other sites in addition to the lung. The largest series, based on a total of 7564 patients with melanoma, found a 12 percent incidence of lung metastases and an associated five-year survival rate of 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the poor prognosis for most patients with melanoma involving the lung, metastasectomy may be useful for symptom palliation and may salvage some patients. The role of pulmonary metastasectomy in patients with melanoma is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/8/2183?source=see_link&amp;anchor=H8#H8\">",
"     \"Surgical management of metastatic melanoma\", section on 'Lung'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     HEAD AND NECK CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Post-surgical survival following resection of pulmonary metastases from head and neck cancer varies by cell type and disease site. These issues are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/25/40345?source=see_link&amp;anchor=H624594020#H624594020\">",
"     \"Treatment of metastatic and recurrent head and neck cancer\", section on 'Oligometastatic disease'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     OSTEOSARCOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Operative resection is the only potentially curative treatment for patients with thoracic metastases from osteogenic sarcoma. Following resection, adjuvant chemotherapy can improve disease-free survival and decrease the burden of metastatic pulmonary disease. Resection of pulmonary metastases should always be part of a combined modality approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39050?source=see_link&amp;anchor=H19#H19\">",
"     \"Chemotherapy and radiation therapy in the management of osteosarcoma\", section on 'Surgery'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39050?source=see_link&amp;anchor=H14#H14\">",
"     \"Chemotherapy and radiation therapy in the management of osteosarcoma\", section on 'Treatment of patients with metastatic disease at diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     BREAST CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of women with metastatic breast cancer involving the lungs includes chemotherapy, hormone therapy (for hormone receptor-positive disease), and, if the tumor expresses HER2,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/39/6776?source=see_link\">",
"     trastuzumab",
"    </a>",
"    . In addition to these approaches, surgical resection of isolated metastases is an important option in carefully selected patients. The role of surgery in this setting is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35831?source=see_link&amp;anchor=H12#H12\">",
"     \"Metastatic breast cancer: Local treatment\", section on 'Lung metastases'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=see_link&amp;anchor=H541712004#H541712004\">",
"     \"Approach to the long-term survivor of breast cancer\", section on 'Role of laboratory and imaging evaluation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26969797\">",
"    <span class=\"h1\">",
"     HEPATOCELLULAR CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following resection of hepatocellular carcinoma (HCC), intrahepatic recurrences are more common than extrahepatic recurrences. While many local ablative treatment modalities are available to address intrahepatic recurrence disease, systemic treatment for extrahepatic disease involvement remains unsatisfactory. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43063?source=see_link\">",
"     \"Overview of treatment approaches for hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/6/14442?source=see_link\">",
"     \"Surgical management of potentially resectable hepatocellular carcinoma\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36138?source=see_link\">",
"     \"Nonsurgical therapies for localized hepatocellular carcinoma: Radiofrequency ablation, percutaneous ethanol injection, thermal ablation, and cryoablation\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39898?source=see_link\">",
"     \"Systemic treatment for advanced hepatocellular carcinoma\"",
"    </a>",
"    .) &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    Selected patients with isolated pulmonary metastases might be considered for potentially curative resection. Few small case series describe long-term outcomes from pulmonary metastasectomy in such patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/32-38\">",
"     32-38",
"    </a>",
"    ]. The range of reported five-year survival rates in completely resected patients is 12 to 67 percent. Among the factors associated with a favorable postresection prognosis in multivariate analysis are:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A relapse-free interval &gt;12 to 24 months [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/32-34\">",
"       32-34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Fewer than three pulmonary metastases [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/34\">",
"       34",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Levels of serum alfa-fetoprotein &lt;500",
"      <span class=\"nowrap\">",
"       mg/mL",
"      </span>",
"      before [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/33\">",
"       33",
"      </a>",
"      ] or &lt;100",
"      <span class=\"nowrap\">",
"       ng/mL",
"      </span>",
"      after [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/32\">",
"       32",
"      </a>",
"      ] metastasectomy",
"     </li>",
"     <li>",
"      Largest size of metastases &lt;3 cm [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/35\">",
"       35",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Whether or not the patient underwent liver transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/36\">",
"       36",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Pulmonary metastasectomy should be limited to those patients who have no evidence of uncontrolled intrahepatic disease, no extrathoracic metastases, and a chest CT demonstrating that complete resection is feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96886119\">",
"    <span class=\"h1\">",
"     GASTRIC CANCER",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pulmonary metastasectomy for metastatic gastric cancer can potentially result in long-term survival in a highly selected group of patients. A review of 21 studies from 1975 to 2008 included 48 pulmonary resections among 43 patients (82 percent solitary lesions) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13560/abstract/39\">",
"     39",
"    </a>",
"    ]. At a median followup of 23 months, 15 (35 percent) remained alive without disease, and two patients died without disease. The median overall survival was higher among patients with a disease-free interval of at least 24 months (65 versus 19 months).",
"   </p>",
"   <p>",
"    This approach should be reserved for those patients who present with small isolated lesions after a prolonged disease-free interval. &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aggressive surgical resection of lung metastases in appropriately selected patients offers a chance for extended disease-free survival that would not be possible with systemic therapy. Retrospective experience has shown that the overall actuarial five- and ten-year survival rates after complete metastasectomy are about 36 and 26 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link\">",
"     \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The survival rate is influenced by the disease-free interval, number of metastases, extent of resection. The potential benefits of resection and the approach to the patient are also dependent upon the histology of the tumor.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Following resection of colorectal cancer lung metastases, we suggest a course of adjuvant chemotherapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). We prefer an",
"      <a class=\"drug drug_general\" href=\"UTD.htm?2/11/2233?source=see_link\">",
"       oxaliplatin",
"      </a>",
"      -based regimen, such as FOLFOX or XELOX (",
"      <a class=\"graphic graphic_table graphicRef64504 \" href=\"UTD.htm?5/20/5454\">",
"       table 2",
"      </a>",
"      ), as is used following resection of colorectal cancer liver metastases. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Benefit of postresection adjuvant therapy'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=see_link&amp;anchor=H20#H20\">",
"       \"Management of potentially resectable colorectal cancer liver metastases\", section on 'Systemic chemotherapy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Systemic therapy is an important component of multimodality treatment of pulmonary metastases in other histologic types as well, including osteosarcoma, breast cancer, germ cell tumors, and choriocarcinoma. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39050?source=see_link&amp;anchor=H14#H14\">",
"       \"Chemotherapy and radiation therapy in the management of osteosarcoma\", section on 'Treatment of patients with metastatic disease at diagnosis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35831?source=see_link&amp;anchor=H12#H12\">",
"       \"Metastatic breast cancer: Local treatment\", section on 'Lung metastases'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38425?source=see_link&amp;anchor=H14#H14\">",
"       \"Surgical management of advanced testicular germ cell tumors\", section on 'Lung lesions'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42234?source=see_link\">",
"       \"Gestational trophoblastic neoplasia: Staging and treatment\"",
"      </a>",
"      .)",
"      <br/>",
"      <br/>",
"      For other histologic tumor types, there are few if any data addressing the benefit of adjuvant systemic therapy, and decisions regarding its use must be individualized.",
"     </li>",
"     <li>",
"      Following treatment, we suggest regular radiographic surveillance with chest CT scans every four months (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Radiographic evidence of recurrence mandates a full evaluation of disease extent and cardiorespiratory reserve. If the indications for pulmonary metastasectomy are still met, a repeat surgical procedure is offered as an alternative to systemic therapy or other locally ablative options. A chest CT scan should be repeated six weeks after the initial observation of suspected recurrence and prior to repeat surgery, as this may reveal additional deposits of recurrence that may preclude surgery. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=see_link&amp;anchor=H29#H29\">",
"       \"Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques\", section on 'Repeat metastasectomy'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/1\">",
"      Farrell J. Pulmonary metastases: pathological, clinical roentgenological study based on 78 cases at necropsy. Radiology 1935; 24:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/2\">",
"      Barney JD. Adenocarcinoma of the kidney with metastases to the lung cured by nephrectomy and lobectomy. J Urol 1939; 42:269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/3\">",
"      Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. The International Registry of Lung Metastases. J Thorac Cardiovasc Surg 1997; 113:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/4\">",
"      Saito Y, Omiya H, Kohno K, et al. Pulmonary metastasectomy for 165 patients with colorectal carcinoma: A prognostic assessment. J Thorac Cardiovasc Surg 2002; 124:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/5\">",
"      Okumura S, Kondo H, Tsuboi M, et al. Pulmonary resection for metastatic colorectal cancer: experiences with 159 patients. J Thorac Cardiovasc Surg 1996; 112:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/6\">",
"      McCormack PM, Burt ME, Bains MS, et al. Lung resection for colorectal metastases. 10-year results. Arch Surg 1992; 127:1403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/7\">",
"      McAfee MK, Allen MS, Trastek VF, et al. Colorectal lung metastases: results of surgical excision. Ann Thorac Surg 1992; 53:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/8\">",
"      Yedibela S, Klein P, Feuchter K, et al. Surgical management of pulmonary metastases from colorectal cancer in 153 patients. Ann Surg Oncol 2006; 13:1538.",
"     </a>",
"    </li>",
"    <li>",
"     Kim S, Kim H, Hong Y, et al. The outcome of pulmonary metastasectomy from colorectal cancer and the role of postoperative chemotherapy (abstract). Data presented at the 2009 ASCO Gastrointestinal cancers Symposium, San Francisco, CA, January 16th, 2009.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/10\">",
"      Rama N, Monteiro A, Bernardo JE, et al. Lung metastases from colorectal cancer: surgical resection and prognostic factors. Eur J Cardiothorac Surg 2009; 35:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/11\">",
"      Lin BR, Chang TC, Lee YC, et al. Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor. Ann Surg Oncol 2009; 16:1026.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/12\">",
"      Kanzaki R, Higashiyama M, Oda K, et al. Outcome of surgical resection for recurrent pulmonary metastasis from colorectal carcinoma. Am J Surg 2011; 202:419.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/13\">",
"      Blackmon SH, Stephens EH, Correa AM, et al. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg 2012; 94:1802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/14\">",
"      Iida T, Nomori H, Shiba M, et al. Prognostic Factors After Pulmonary Metastasectomy for Colorectal Cancer and Rationale for Determining Surgical Indications: A Retrospective Analysis. Ann Surg 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/15\">",
"      Tampellini M, Ottone A, Bellini E, et al. The role of lung metastasis resection in improving outcome of colorectal cancer patients: results from a large retrospective study. Oncologist 2012; 17:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/16\">",
"      Watanabe K, Nagai K, Kobayashi A, et al. Factors influencing survival after complete resection of pulmonary metastases from colorectal cancer. Br J Surg 2009; 96:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/17\">",
"      Koga R, Yamamoto J, Saiura A, et al. Surgical resection of pulmonary metastases from colorectal cancer: Four favourable prognostic factors. Jpn J Clin Oncol 2006; 36:643.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/18\">",
"      Iizasa T, Suzuki M, Yoshida S, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. Ann Thorac Surg 2006; 82:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/19\">",
"      Welter S, Jacobs J, Krbek T, et al. Prognostic impact of lymph node involvement in pulmonary metastases from colorectal cancer. Eur J Cardiothorac Surg 2007; 31:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/20\">",
"      Onaitis MW, Petersen RP, Haney JC, et al. Prognostic factors for recurrence after pulmonary resection of colorectal cancer metastases. Ann Thorac Surg 2009; 87:1684.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/21\">",
"      Patel NA, Keenan RJ, Medich DS, et al. The presence of colorectal hepatic metastases does not preclude pulmonary metastasectomy. Am Surg 2003; 69:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/22\">",
"      Mise Y, Imamura H, Hashimoto T, et al. Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg 2010; 251:902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/23\">",
"      Gonzalez M, Robert JH, Halkic N, et al. Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases. World J Surg 2012; 36:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/24\">",
"      Mitry E, Fields AL, Bleiberg H, et al. Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol 2008; 26:4906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/25\">",
"      Mountain CF, McMurtrey MJ, Hermes KE. Surgery for pulmonary metastasis: a 20-year experience. Ann Thorac Surg 1984; 38:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/26\">",
"      Murthy SC, Kim K, Rice TW, et al. Can we predict long-term survival after pulmonary metastasectomy for renal cell carcinoma? Ann Thorac Surg 2005; 79:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/27\">",
"      van der Poel HG, Roukema JA, Horenblas S, et al. Metastasectomy in renal cell carcinoma: A multicenter retrospective analysis. Eur Urol 1999; 35:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/28\">",
"      Cerfolio RJ, Allen MS, Deschamps C, et al. Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 1994; 57:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/29\">",
"      Hofmann HS, Neef H, Krohe K, et al. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol 2005; 48:77.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/30\">",
"      Anraku M, Yokoi K, Nakagawa K, et al. Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients. J Thorac Cardiovasc Surg 2004; 127:1107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/31\">",
"      Harpole DH Jr, Johnson CM, Wolfe WG, et al. Analysis of 945 cases of pulmonary metastatic melanoma. J Thorac Cardiovasc Surg 1992; 103:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/32\">",
"      Cho S, Ryu KM, Hwang YJ, Lee EB. Prognostic factors for pulmonary metastasectomy in the treatment of hepatocellular carcinoma. J Thorac Oncol 2010; 5:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/33\">",
"      Nakagawa T, Kamiyama T, Nakanishi K, et al. Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. J Thorac Cardiovasc Surg 2006; 131:1248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/34\">",
"      Kuo SW, Chang YL, Huang PM, et al. Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 2007; 14:992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/35\">",
"      Chen F, Sato K, Fujinaga T, et al. Pulmonary resection for metastases from hepatocellular carcinoma. World J Surg 2008; 32:2213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/36\">",
"      Kwon JB, Park K, Kim YD, et al. Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors. World J Gastroenterol 2008; 14:5717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/37\">",
"      Han KN, Kim YT, Yoon JH, et al. Role of surgical resection for pulmonary metastasis of hepatocellular carcinoma. Lung Cancer 2010; 70:295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/38\">",
"      Yoon YS, Kim HK, Kim J, et al. Long-term survival and prognostic factors after pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 2010; 17:2795.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13560/abstract/39\">",
"      Kemp CD, Kitano M, Kerkar S, et al. Pulmonary resection for metastatic gastric cancer. J Thorac Oncol 2010; 5:1796.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2796 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-118.97.94.19-90DFCF4173-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13560=[""].join("\n");
var outline_f13_15_13560=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SOFT TISSUE SARCOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      COLORECTAL CANCER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Significance of synchronous or metachronous liver metastases",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Benefit of postresection adjuvant therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      RENAL CELL CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      GERM CELL CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      GYNECOLOGIC CANCERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MELANOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      HEAD AND NECK CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      OSTEOSARCOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      BREAST CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26969797\">",
"      HEPATOCELLULAR CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H96886119\">",
"      GASTRIC CANCER",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/2796\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/2796|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/53/17246\" title=\"table 1\">",
"      Modified FOLFOX6",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/20/5454\" title=\"table 2\">",
"      Chemo regimens met CRC",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/44/34506?source=related_link\">",
"      Adjuvant therapy for resected stage III (node-positive) colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/12/5322?source=related_link\">",
"      Approach to the long-term survivor of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/8/39050?source=related_link\">",
"      Chemotherapy and radiation therapy in the management of osteosarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/15/42234?source=related_link\">",
"      Gestational trophoblastic neoplasia: Staging and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/63/24568?source=related_link\">",
"      Initial risk-stratified treatment for advanced testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/49/6938?source=related_link\">",
"      Invasive cervical adenocarcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/55/41850?source=related_link\">",
"      Management of potentially resectable colorectal cancer liver metastases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/37/33368?source=related_link\">",
"      Management of recurrent or metastatic cervical cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/63/35831?source=related_link\">",
"      Metastatic breast cancer: Local treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/18/36138?source=related_link\">",
"      Nonsurgical therapies for localized hepatocellular carcinoma: Radiofrequency ablation, percutaneous ethanol injection, thermal ablation, and cryoablation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/3/43063?source=related_link\">",
"      Overview of treatment approaches for hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/44/21192?source=related_link\">",
"      Prognostic factors in patients with renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/6/22630?source=related_link\">",
"      Role of surgery in patients with metastatic renal cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/33/38425?source=related_link\">",
"      Surgical management of advanced testicular germ cell tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/8/2183?source=related_link\">",
"      Surgical management of metastatic melanoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/6/14442?source=related_link\">",
"      Surgical management of potentially resectable hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13834?source=related_link\">",
"      Surgical resection of pulmonary metastases: Benefits; indications; preoperative evaluation and techniques",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/40/44680?source=related_link\">",
"      Surgical treatment and other localized therapy for metastatic soft tissue sarcoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/32/44554?source=related_link\">",
"      Systemic chemotherapy for metastatic colorectal cancer: Completed clinical trials",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/1/44058?source=related_link\">",
"      Systemic chemotherapy for nonoperable metastatic colorectal cancer: Treatment recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/61/39898?source=related_link\">",
"      Systemic treatment for advanced hepatocellular carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/18/22825?source=related_link\">",
"      Treatment of locally advanced, recurrent, or metastatic endometrial cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/25/40345?source=related_link\">",
"      Treatment of metastatic and recurrent head and neck cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_15_13561="Acute uncomplicated cystitis and pyelonephritis in women";
var content_f13_15_13561=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"topicTitle\">",
"   Acute uncomplicated cystitis and pyelonephritis in women",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13561/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13561/contributors\">",
"     Thomas M Hooton, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13561/contributors\">",
"     Kalpana Gupta, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13561/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13561/contributors\">",
"     Stephen B Calderwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?13/15/13561/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?13/15/13561/contributors\">",
"     Allyson Bloom, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?13/15/13561/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 6, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H899949128\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute cystitis refers to infection of the bladder (lower urinary tract); it can occur alone or in conjunction with pyelonephritis (infection of the kidney &ndash; the upper urinary tract) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most episodes of cystitis and pyelonephritis are generally considered to be uncomplicated in otherwise healthy nonpregnant adult women. A complicated urinary tract infection, whether localized to the lower or upper tract, is associated with an underlying condition that increases the risk of infection or of failing therapy (such as obstruction, anatomic abnormality, urologic dysfunction, or a multiply-resistant uropathogen).",
"   </p>",
"   <p>",
"    Issues related to acute uncomplicated cystitis and pyelonephritis in women will be reviewed here. Issues related to urinary tract infections in men and acute complicated urinary tract infections are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=see_link\">",
"     \"Acute complicated cystitis and pyelonephritis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=see_link\">",
"     \"Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949142\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among sexually active young women, the incidence of symptomatic urinary tract infection (UTI) is high; in one university cohort of 796 women, the incidence was 0.5 to 0.7 UTIs per person-year [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/2\">",
"     2",
"    </a>",
"    ]. Risk factors include recent sexual intercourse, recent spermicide use, and a history of urinary tract infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/2,3\">",
"     2,3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cystitis also occurs in postmenopausal women. In a prospective cohort study of 1017 postmenopausal women followed for two years, the estimated incidence of culture-confirmed acute cystitis was 0.07 episodes per person per year [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/4\">",
"     4",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    Acute pyelonephritis is less common than acute cystitis; in one review including over 3200 patients with a first episode of acute pyelonephritis, the annual incidence of acute pyelonephritis was 12 to 13 cases per 10,000 women [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949149\">",
"    <span class=\"h1\">",
"     PATHOGENESIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pathogenesis of urinary tract infection in women begins with colonization of the vaginal introitus by uropathogens from the fecal flora, followed by ascension via the urethra into the bladder. Pyelonephritis develops when pathogens ascend to the kidneys via the ureters. Host and microbial factors that underlie progression from bladder to kidney infection require further investigation.",
"   </p>",
"   <p>",
"    Pyelonephritis can also be caused by seeding of the kidneys from bacteremia. It is possible that some cases of pyelonephritis are associated with seeding of the kidneys from bacteria in the lymphatics.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949156\">",
"    <span class=\"h1\">",
"     MICROBIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The microbial spectrum of uncomplicated cystitis and pyelonephritis in women consists mainly of Escherichia coli (75 to 95 percent), with occasional other species of Enterobacteriaceae, such as Proteus mirabilis and Klebsiella pneumoniae, and other bacteria such as Staphylococcus saprophyticus [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Other gram-negative and gram-positive species are rarely isolated in uncomplicated UTIs. Therefore, local antimicrobial susceptibility patterns of E. coli in particular should be considered in empiric antimicrobial selection for uncomplicated UTIs.",
"   </p>",
"   <p>",
"    Among otherwise healthy nonpregnant women, the isolation of organisms such as lactobacilli, enterococci, Group B streptococci, and coagulase-negative staphylococci other than S. saprophyticus most commonly represents contamination of the urine specimen [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. However, such organisms should be considered a likely causative agent in symptomatic women when found in voided midstream urine at high counts and with pure growth. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949163\">",
"    <span class=\"h2\">",
"     Antimicrobial resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is considerable geographic variability among E. coli for in vitro susceptibility. In four large studies, resistance rates were higher in US medical centers than in Canadian medical centers, and higher in Portugal and Spain than other European countries [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. In general, resistance rates &gt;20 percent were reported in all regions for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    , and in many regions for",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    (with or without sulfamethoxazole). Fluoroquinolone resistance rates were &lt;10 percent in most parts of North America and Europe, but there was a clear trend for increasing resistance over time [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/9-14\">",
"     9-14",
"    </a>",
"    ]. In fact, in a subsequent study of E. coli urinary isolates from outpatients in the United States, resistance rates to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    were shown to increase from 3 to 17 percent between 2000 and 2010 among the population examined [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/13\">",
"     13",
"    </a>",
"    ]. However, passive laboratory-based surveillance methods tend to overestimate true resistance rates since they are skewed by urine cultures obtained from patients who may have failed initial therapy or who have specific risk factors for resistance, such as recent travel or antimicrobial use [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/15-17\">",
"     15-17",
"    </a>",
"    ]. Resistance rates for first and second generation oral cephalosporins and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"     amoxicillin",
"    </a>",
"    -clavulanic acid are regionally variable but generally &lt;10 percent.",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     Nitrofurantoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6724?source=see_link\">",
"     fosfomycin",
"    </a>",
"    , and mecillinam (not available in the US) had good in vitro activity in all countries investigated [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. These patterns suggest these three last agents are appropriate antimicrobials for empiric therapy in most regions. Ongoing monitoring of resistance is necessary for optimization of empiric therapy. (See",
"    <a class=\"local\" href=\"#H899949198\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     Trimethoprim-sulfamethoxazole",
"    </a>",
"    is the agent for which there are the most data to guide clinical use. In studies evaluating epidemiological predictors of resistance, the use of TMP-SMX in the preceding three to six months and travel, particularly international travel, were independent risk factors for TMP-SMX resistance in women with acute uncomplicated cystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/18-21\">",
"     18-21",
"    </a>",
"    ]. In addition, clinical, in vitro, and mathematical modeling studies have suggested a 20 percent resistance prevalence as the threshold at which TMP-SMX should not be used for treatment of acute cystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/22,23\">",
"     22,23",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H899949213\">",
"     'Cystitis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    For other antimicrobial agents, there are insufficient data to determine the resistance levels at which the likelihood of failure outweighs the potential benefits; the decision depends on individual practitioner discretion. In addition, it is important for clinicians to understand that local resistance rates reported in hospital antibiograms are often skewed by cultures of samples obtained from inpatients or those with complicated infection and may not accurately predict susceptibilities in women with uncomplicated community-acquired infection, in whom resistance rates tend to be lower [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/24,25\">",
"     24,25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Infections caused by extended-spectrum beta-lactamase (ESBL) - producing strains are increasing in number, even in the setting of uncomplicated urinary tract infection [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/26-28\">",
"     26-28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949170\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical manifestations of cystitis consist of dysuria, frequency, urgency, suprapubic pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/29\">",
"     29",
"    </a>",
"    ]. Symptoms of cystitis can be subtle in the very young and very old.",
"   </p>",
"   <p>",
"    Clinical manifestations of pyelonephritis consist of the above symptoms (symptoms of cystitis may or may not be present) together with fever (&gt;38&ordm;C), chills, flank pain, costovertebral angle tenderness, and",
"    <span class=\"nowrap\">",
"     nausea/vomiting",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/30\">",
"     30",
"    </a>",
"    ]. In some cases, the presentation may mimic pelvic inflammatory disease. Rarely, patients with acute pyelonephritis present with sepsis, multiple organ system dysfunction, shock,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    acute renal failure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949177\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of uncomplicated cystitis or pyelonephritis begins with assessment of the clinical history, guided by the clinical manifestations above. The probability of cystitis is greater than 50 percent in women with any symptom of urinary tract infection and greater than 90 percent in women who have dysuria and frequency without vaginal discharge or irritation [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/29\">",
"     29",
"    </a>",
"    ]. Physical examination should include assessment for fever, costovertebral angle tenderness, and abdominal examination. A pelvic examination is indicated if factors suggesting vaginitis or urethritis are present. Pregnancy testing may also be appropriate.",
"   </p>",
"   <p>",
"    Laboratory diagnostic tools consist of urinalysis (either by microscopy or by dipstick) and urine culture with susceptibility data. Urinalysis in the absence of urine culture is sufficient for diagnosis of uncomplicated cystitis if symptoms are consistent with UTI, unless there is reason to suspect antimicrobial resistance or other complicating features.",
"   </p>",
"   <p>",
"    Imaging studies are not routinely required for diagnosis of acute uncomplicated pyelonephritis but can be helpful in certain circumstances. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=see_link&amp;anchor=H2922574#H2922574\">",
"     \"Acute complicated cystitis and pyelonephritis\", section on 'Radiographic imaging'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949184\">",
"    <span class=\"h2\">",
"     Urinalysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urinalysis for evaluation of pyuria is the most valuable laboratory diagnostic test for UTI. Pyuria is present in almost all women with acute cystitis or pyelonephritis; its absence strongly suggests an alternative diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/31,32\">",
"     31,32",
"    </a>",
"    ] or, in a patient with pyelonephritis, the presence of an obstructing lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The most accurate method for assessing pyuria is to examine an unspun voided midstream urine specimen with a hemocytometer; an abnormal result is &ge;10",
"    <span class=\"nowrap\">",
"     leukocytes/microL",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/31\">",
"     31",
"    </a>",
"    ]. White blood cell casts in the urine are diagnostic of upper tract infection. The presence of hematuria is helpful since it is common in the setting of UTI but not in urethritis or vaginitis. Hematuria is not a predictor for complicated infection and does not warrant extended therapy.",
"   </p>",
"   <p>",
"    Dipsticks are commercially available strips that detect the presence of leukocyte esterase (an enzyme released by leukocytes, reflecting pyuria) and nitrite (reflecting the presence of Enterobacteriaceae, which convert urinary nitrate to nitrite):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Leukocyte esterase may be used to detect &gt;10 leukocytes per high power field (sensitivity of 75 to 96 percent; specificity of 94 to 98 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The nitrite test is fairly sensitive and specific for detecting &ge;10(5) CFU of Enterobacteriaceae per mL of urine, though it lacks adequate sensitivity for detection of other organisms, so negative results should be interpreted with caution [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/33,34\">",
"       33,34",
"      </a>",
"      ]. False positive nitrite tests can occur with substances that turn the urine red, such as the bladder analgesic",
"      <a class=\"drug drug_general\" href=\"UTD.htm?40/7/41075?source=see_link\">",
"       phenazopyridine",
"      </a>",
"      or ingestion of beets. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=see_link&amp;anchor=H4#H4\">",
"       \"Urinalysis in the diagnosis of kidney disease\", section on 'Red to brown urine'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The dipstick test is most accurate for predicting UTI when positive for either leukocyte esterase or nitrite, with a sensitivity of 75 percent and a specificity of 82 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/29\">",
"       29",
"      </a>",
"      ]. However, results of the dipstick test provide little useful information when the history is strongly suggestive of urinary tract infection, since even negative results for both tests do not reliably rule out the infection in such cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949191\">",
"    <span class=\"h2\">",
"     Urine culture",
"    </span>",
"    &nbsp;&mdash;&nbsp;The causative organisms and their antimicrobial susceptibility profiles are frequently predictable in women with uncomplicated UTI. However, given the increasing prevalence of antimicrobial resistance among uropathogens, obtaining a urine culture prior to initiation of therapy is warranted if symptoms are not characteristic of UTI, if symptoms persist or recur within three months following prior antimicrobial therapy, or if a complicated infection is suspected [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/35-38\">",
"     35-38",
"    </a>",
"    ]. In addition, urine culture and antimicrobial susceptibility testing of uropathogens should be performed in all women with acute pyelonephritis.",
"   </p>",
"   <p>",
"    Growth of organisms generally thought to be contaminants should be considered a likely causative agent when found in voided midstream urine at high counts and with pure growth. (See",
"    <a class=\"local\" href=\"#H899949156\">",
"     'Microbiology'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Issues related to interpretation of urine culture colony counts are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?23/41/24214?source=see_link&amp;anchor=H3#H3\">",
"     \"Urine sampling and culture in the diagnosis of urinary tract infection in adults\", section on 'Definition of a positive culture'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1425706\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;In otherwise healthy women, both infectious and noninfectious processes can cause symptoms of dysuria, frequency, urgency, suprapubic pain,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    hematuria [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Vaginitis &ndash; In women with dysuria, the presence of vaginal discharge or odor, pruritus, dyspareunia, and absence of urinary frequency or urgency should prompt consideration of vaginitis. Causes of vaginitis include yeast infection, trichomoniasis, and bacterial vaginosis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=see_link\">",
"       \"Approach to women with symptoms of vaginitis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urethritis &ndash; Evaluation for urethritis is warranted in sexually active women with dysuria, particularly those with pyuria on urinalysis but no bacteriuria. Causes of urethritis in women include chlamydia, gonorrhea, trichomoniasis, Candida species, herpes simplex virus, and non-infectious irritants, such as a contraceptive gel. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/30/10729?source=see_link&amp;anchor=H9967056#H9967056\">",
"       \"Clinical manifestations and diagnosis of Chlamydia trachomatis infections\", section on 'Dysuria-pyuria syndrome due to urethritis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Structural urethral abnormalities &ndash; Women with urethral diverticula or strictures can present with dysuria, frequency or urgency, and gross or macroscopic hematuria. Although they may have persistent sterile pyuria, bacteriuria is not present in the absence of an infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26873?source=see_link\">",
"       \"Urethral diverticulum in women\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Painful bladder syndrome &ndash; This is a diagnosis of exclusion in women who have ongoing discomfort related to the bladder with symptoms of dysuria, frequency,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      urgency but no evidence of infection or other identifiable cause. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=see_link\">",
"       \"Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Pelvic inflammatory disease &ndash; Lower abdominal or pelvic pain and fever are the most common clinical findings in patients with pelvic inflammatory disease (PID), although dysuria may also be present. The findings of mucopurulent endocervical discharge or cervical motion tenderness on pelvic examination are strongly suggestive of PID. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=see_link\">",
"       \"Clinical features and diagnosis of pelvic inflammatory disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Nephrolithiasis &ndash; The majority of patients with symptomatic nephrolithiasis have flank",
"      <span class=\"nowrap\">",
"       pain/renal",
"      </span>",
"      colic in addition to gross or microscopic hematuria. In the absence of infection, fever is unusual in patients with nephrolithiasis. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=see_link\">",
"       \"Diagnosis and acute management of suspected nephrolithiasis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949198\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949213\">",
"    <span class=\"h2\">",
"     Cystitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Considerations in selecting an agent for treatment of acute cystitis include efficacy, risk of adverse effects, resistance rates, propensity to cause ecological adverse effects of antimicrobial therapy (such as selection of drug-resistant organisms and development of colonization or infection with multidrug-resistant organisms), cost, and drug availability [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ]. None of the antimicrobials currently available clearly outweighs the others in terms of optimizing each of these factors for treatment of acute cystitis, and the optimal antimicrobial in one region may be different from that in another.",
"   </p>",
"   <p>",
"    Appropriate antimicrobials for treatment of acute uncomplicated cystitis in women include [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"       Nitrofurantoin",
"      </a>",
"      <span class=\"nowrap\">",
"       monohydrate/macrocrystals",
"      </span>",
"      (100 mg orally twice daily for 5 days); early clinical efficacy rate with 5 to 7 day regimen 90 to 95 percent based on randomized trials [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/39-42\">",
"       39-42",
"      </a>",
"      ] and minimal resistance and ecological adverse effects. Nitrofurantoin should be avoided if there is suspicion for early pyelonephritis, and is contraindicated when creatinine clearance is &lt;60",
"      <span class=\"nowrap\">",
"       mL/minute.",
"      </span>",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       Trimethoprim-sulfamethoxazole",
"      </a>",
"      (TMP-SMX; one double strength tablet",
"      <span class=\"nowrap\">",
"       [160/800",
"      </span>",
"      mg] twice daily for 3 days); early clinical efficacy rate with 3 to 7 day regimen 86 to 100 percent based on randomized trials [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/39,40,43,44\">",
"       39,40,43,44",
"      </a>",
"      ]. Empiric TMP-SMX should be avoided if the prevalence of resistance is known to exceed 20 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/22,23\">",
"       22,23",
"      </a>",
"      ] or if the patient has taken TMP-SMX for cystitis in the preceding 3 months [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/18,19\">",
"       18,19",
"      </a>",
"      ], although use of TMP-SMX is acceptable if the infecting strain is known to be susceptible. In some regions",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"       trimethoprim",
"      </a>",
"      (100 mg twice daily for three days) is used in place of TMP-SMX and is considered equivalent [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/35\">",
"       35",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H899949163\">",
"       'Antimicrobial resistance'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6724?source=see_link\">",
"       Fosfomycin",
"      </a>",
"      trometamol (3 grams single dose); clinical efficacy rate 91 percent based on a single randomized trial [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/41\">",
"       41",
"      </a>",
"      ], but bacterial efficacy inferior compared with other first-line agents [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/45\">",
"       45",
"      </a>",
"      ]; minimal resistance and ecological adverse effects. Fosfomycin should be avoided if there is suspicion for early pyelonephritis.",
"     </li>",
"     <li>",
"      Pivmecillinam (400 mg orally twice daily for 3 to 7 days); clinical efficacy 55 to 82 percent based on randomized trials [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/46,47\">",
"       46,47",
"      </a>",
"      ] is lower than other first-line agents, but minimal resistance and ecological adverse effects. Pivmecillinam is an extended gram-negative spectrum penicillin used only for treatment of UTI. It is not available in the United States but is an agent of choice in many Nordic countries due to low resistance rates and low propagation of resistance [",
"      <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/48\">",
"       48",
"      </a>",
"      ]. Pivmecillinam should be avoided if there is suspicion for early pyelonephritis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The choice between these agents should be individualized based on patient circumstances (allergy, tolerability, compliance), local community resistance prevalence, availability, cost, and patient and provider threshold for failure. If these factors preclude use of the above antibiotics, fluoroquinolones (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/60/35776?source=see_link\">",
"     ofloxacin",
"    </a>",
"    in 3-day regimens) are reasonable alternative agents, though, when possible, fluoroquinolones should be reserved for important uses other than acute cystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/49\">",
"     49",
"    </a>",
"    ]. Multiple randomized trials have demonstrated that fluoroquinolones are very effective for treatment of acute cystitis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/40,47,50-56\">",
"     40,47,50-56",
"    </a>",
"    ], although increased resistance is mitigating the usefulness of the fluoroquinolone class.",
"   </p>",
"   <p>",
"    <a class=\"external\" href=\"file://www.uptodate.com/contents/nitrofurantoin-drug-information?source=see_link\">",
"     Nitrofurantoin",
"    </a>",
"    &nbsp;and",
"    <a class=\"external\" href=\"file://www.uptodate.com/contents/fosfomycin-drug-information?source=see_link\">",
"     fosfomycin",
"    </a>",
"    &nbsp;are active in vitro against extended-spectrum beta-lactamase (ESBL) producing strains [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/28,57\">",
"     28,57",
"    </a>",
"    ]. In a case-control study including 113 patients with ESBL E. coli UTIs, no resistance to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6724?source=see_link\">",
"     fosfomycin",
"    </a>",
"    was detected and clinical cure rates were high (93 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oral beta lactams (other than pivmecillinam discussed above) are less effective than fluoroquinolones and TMP-SMX [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/35,56,58\">",
"     35,56,58",
"    </a>",
"    ]. Acceptable beta lactam agents include amoxicillin-clavulanate, cefpodoxime, cefdinir and cefaclor, for duration of seven days [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/44,55,56\">",
"     44,55,56",
"    </a>",
"    ]. Cefpodoxime (three-day regimen) did not meet criteria for noninferiority to ciprofloxacin (three-day regimen) for clinical cure of acute uncomplicated cystitis in a randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/59\">",
"     59",
"    </a>",
"    ]. Other beta lactams, such as cephalexin, are less well studied but may be acceptable in certain settings. Ampicillin or amoxicillin should NOT be used for empiric treatment given poor efficacy and high prevalence of resistance to these agents [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/9-12,35\">",
"     9-12,35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If there is diagnostic uncertainty regarding cystitis versus early pyelonephritis, use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6724?source=see_link\">",
"     fosfomycin",
"    </a>",
"    and pivmecillinam should be avoided because they do not achieve adequate renal tissue levels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Given that cystitis is associated with increasing antimicrobial resistance and has a low risk of progression to invasive disease, antimicrobial-sparing management strategies are of increasing interest (eg, antiinflammatory drugs or delayed treatment), but warrant further study [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/60,61\">",
"     60,61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949220\">",
"    <span class=\"h2\">",
"     Pyelonephritis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urine culture and susceptibility testing should be performed in patients with known or suspected pyelonephritis, and initial empiric therapy should be tailored appropriately on the basis of the infecting pathogen [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ]. The approach to empiric therapy depends on the severity of illness, the prevalence of resistant pathogens in the community, and specific host factors such as allergy or intolerance history [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Pyelonephritis is a more serious infection than cystitis; therefore, expected efficacy of an antimicrobial agent is of greater importance than concern about ecological adverse effects (selection of drug-resistant organisms and the development of colonization or infection with multidrug-resistant organisms) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Outpatient management is acceptable for patients with mild to moderate illness who can be stabilized with rehydration and antibiotics in an outpatient facility and discharged on oral antibiotics under close supervision. In an emergency department report of 44 patients with pyelonephritis, for example, a 12 hour observation period with parenteral antibiotic therapy, followed by completion of outpatient oral antibiotics, was effective management for 97 percent of patients [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/62\">",
"     62",
"    </a>",
"    ]. Inpatient management is warranted in the setting of severe illness with high fever, pain, and marked debility, inability to maintain oral hydration or take oral medications, pregnancy, or concerns about patient compliance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949227\">",
"    <span class=\"h3\">",
"     Outpatient",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fluoroquinolones are the only oral antimicrobials recommended for the outpatient empirical treatment of acute uncomplicated pyelonephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ]. Although fluoroquinolones remain highly effective for treatment of pyelonephritis when the infecting pathogen is susceptible, there is increasing resistance to this drug class even among community uropathogens [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/13\">",
"     13",
"    </a>",
"    ]. Since timely use of an agent with in vitro activity is essential to treat pyelonephritis and minimize progression of infection, the threshold for selecting an antibiotic for empiric broad-spectrum therapy should be set at a relatively low resistance prevalence. For fluoroquinolones, a resistance prevalence of 10 percent has been suggested based on expert opinion [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, for patients with mild to moderate pyelonephritis in whom the likelihood of fluoroquinolone resistance is expected to be less than 10 percent (ie, the community prevalence is not known to be higher than 10 percent, there has been no travel to an area with endemic resistance &gt;10 percent, and there has been no exposure to a fluoroquinolone in the last three to six months), we suggest a fluoroquinolone for empiric therapy (",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    [500 mg orally twice daily for seven days or 1000 mg extended release once daily for seven days] or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    [750 mg orally once daily for five to seven days]) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/63-67\">",
"     63-67",
"    </a>",
"    ]. This can be administered with or without an initial intravenous dose of a long-acting parenteral antimicrobial (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    1 gram or a consolidated 24-hour dose of an aminoglycoside) [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/63,68\">",
"     63,68",
"    </a>",
"    ]. In contrast, for patients with more severe pyelonephritis or risk factors for resistance, intravenous therapy with such a long-acting parenteral antimicrobial should be administered until susceptibility data are available. In all cases, subsequent therapy should be tailored based on susceptibility data.",
"   </p>",
"   <p>",
"    In the setting of fluoroquinolone hypersensitivity or known resistance, other acceptable choices include",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    <span class=\"nowrap\">",
"     (160/800",
"    </span>",
"    mg [one double-strength tablet] twice-daily) or an oral beta-lactam, if the uropathogen is known to be susceptible. If either of these agents is used in the absence of susceptibility data, an initial intravenous dose of a long-acting parenteral antimicrobial should be administered (such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"     ceftriaxone",
"    </a>",
"    or a consolidated 24 hour dose of an aminoglycoside). Patients unable to tolerate these agents (due to hypersensitivity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    resistance) may be treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?42/25/43414?source=see_link\">",
"     aztreonam",
"    </a>",
"    (1 g IV every 8 to 12 hours). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/30/8679?source=see_link\">",
"     \"Consolidated aminoglycoside dosing with gentamicin and tobramycin\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Subsequent therapy should be guided by susceptibility data. Appropriate options include oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"     ciprofloxacin",
"    </a>",
"    , oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"     levofloxacin",
"    </a>",
"    or oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/63-65\">",
"     63-65",
"    </a>",
"    ]. Ciprofloxacin in a seven-day regimen or levofloxacin in a five- to seven-day regimen can be used in most patients with mild to moderate disease who have a rapid response to treatment. The duration of treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/36/26182?source=see_link\">",
"     trimethoprim",
"    </a>",
"    -sulfamethoxazole approved by the United States Food and Drug administration is 14 days, but clinical experience suggests that 7 to 10 days is effective in women who have a rapid response to treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Oral beta lactam agents are less effective than other agents for treatment of pyelonephritis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/35,69\">",
"     35,69",
"    </a>",
"    ]. If the pathogen is susceptible and an oral beta lactam agent is continued, it should be administered for at least 14 days.",
"   </p>",
"   <p>",
"    Use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"     nitrofurantoin",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6724?source=see_link\">",
"     fosfomycin",
"    </a>",
"    , and pivmecillinam should be avoided in the setting of pyelonephritis because they do not achieve adequate renal tissue levels [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949234\">",
"    <span class=\"h3\">",
"     Inpatient",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with pyelonephritis requiring hospitalization should be treated initially with an intravenous antimicrobial regimen such as a fluoroquinolone, an aminoglycoside (with or without",
"    <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"     ampicillin",
"    </a>",
"    ), an extended-spectrum cephalosporin, an extended-spectrum penicillin, or a carbapenem [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/7\">",
"     7",
"    </a>",
"    ]. The choice between these agents should be based on local resistance data and tailored on the basis of susceptibility results.",
"   </p>",
"   <p>",
"    Pyelonephritis caused by extended-spectrum beta-lactamase (ESBL)-producing strains should be treated with a carbapenem [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/70,71\">",
"     70,71",
"    </a>",
"    ]. Empiric antibacterial coverage for ESBL-producing organisms is warranted for patients presenting with sepsis involving the urinary tract [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/70\">",
"     70",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30553?source=see_link\">",
"     \"Extended-spectrum beta-lactamases\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients initially treated with parenteral therapy who improve clinically and can tolerate oral fluids may transition to oral antibiotic therapy. Fluoroquinolone serum levels achieved with oral and intravenous dosing are equivalent, and the modes of delivery are equally effective clinically [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/72\">",
"     72",
"    </a>",
"    ]. Regimens and dosing are as outlined in the preceding section. (See",
"    <a class=\"local\" href=\"#H899949227\">",
"     'Outpatient'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The duration of antibiotic therapy need not be extended in the setting of bacteremia in the absence of other complicating factors; there is no evidence that bacteremia portends a worse prognosis [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949241\">",
"    <span class=\"h2\">",
"     Follow-up",
"    </span>",
"    &nbsp;&mdash;&nbsp;Follow-up urine cultures are not needed in patients with acute cystitis or pyelonephritis whose symptoms resolve on antibiotics.",
"   </p>",
"   <p>",
"    Patients with acute cystitis or pyelonephritis who have persistent symptoms after 48 to 72 hours of appropriate antimicrobial therapy or recurrent symptoms within a few weeks of treatment should have evaluation for complicated infection as discussed separately. Urine culture should be repeated and empiric treatment should be initiated with another antimicrobial agent. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=see_link\">",
"     \"Acute complicated cystitis and pyelonephritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949248\">",
"    <span class=\"h2\">",
"     Symptomatic therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical manifestations should respond to antimicrobial therapy within 48 hours. In the interim, for some patients with cystitis a urinary analgesic such as over-the-counter oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/7/41075?source=see_link\">",
"     phenazopyridine",
"    </a>",
"    three times daily as needed may be useful to relieve discomfort due to severe dysuria. A two-day course is usually sufficient to allow time for symptomatic response to antimicrobial therapy and minimize inflammation. In fact, dysuria is usually diminished within a few hours after the start of antimicrobial therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?13/15/13561/abstract/73\">",
"     73",
"    </a>",
"    ]. This agent should not be used chronically since it may mask clinical symptoms requiring clinical evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20210?source=see_link\">",
"       \"Patient information: Urinary tract infections in adults (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?31/18/32036?source=see_link\">",
"       \"Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?27/25/28048?source=see_link\">",
"       \"Patient information: Kidney infection (pyelonephritis) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H899949262\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute cystitis refers to infection of the bladder (lower urinary tract); it can occur alone or in conjunction with pyelonephritis (infection of the kidney &ndash; the upper urinary tract). Cystitis and pyelonephritis are generally considered to be uncomplicated in otherwise healthy nonpregnant adult women. Risk factors include recent sexual intercourse, recent spermicide use, and a history of urinary tract infection. (See",
"      <a class=\"local\" href=\"#H899949142\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The microbial spectrum of uncomplicated cystitis and pyelonephritis in women consists mainly of Escherichia coli (75 to 95 percent), with occasional other species of Enterobacteriaceae, such as Proteus mirabilis and Klebsiella pneumoniae, and other bacteria such as Staphylococcus saprophyticus. (See",
"      <a class=\"local\" href=\"#H899949156\">",
"       'Microbiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical manifestations of cystitis consist of dysuria, frequency, urgency, suprapubic pain",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      hematuria. Clinical manifestations of pyelonephritis consist of the above symptoms (symptoms of cystitis may or may not be present) together with fever (&gt;38&ordm;C), chills, flank pain, costovertebral angle tenderness, and",
"      <span class=\"nowrap\">",
"       nausea/vomiting.",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H899949170\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Laboratory diagnostic tools consist of urinalysis (either by microscopy or by dipstick) and urine culture with susceptibility data. Imaging studies are not routinely required for diagnosis of acute uncomplicated pyelonephritis but can be helpful in certain circumstances. (See",
"      <a class=\"local\" href=\"#H899949177\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For treatment of acute uncomplicated cystitis in women, we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/22/25958?source=see_link\">",
"       nitrofurantoin",
"      </a>",
"      (100 mg orally twice daily for five days),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"       trimethoprim-sulfamethoxazole",
"      </a>",
"      (TMP-SMX; one double strength tablet",
"      <span class=\"nowrap\">",
"       [160/800",
"      </span>",
"      mg] twice daily for three days),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?6/36/6724?source=see_link\">",
"       fosfomycin",
"      </a>",
"      (3 grams single dose), or pivmecillinam (400 mg orally twice daily for three to seven days) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). TMP-SMX should be avoided if the prevalence of resistance is known to exceed 20 percent or if the patient has taken TMP-SMX in the preceding three months, although its use is acceptable if the infecting strain is known to be susceptible. The choice between these agents should be individualized based on patient circumstances (allergy, tolerability, compliance), local community resistance prevalence, availability, and cost. Fluoroquinolones are reasonable alternative agents, although when possible they should be reserved for important uses other than acute cystitis. (See",
"      <a class=\"local\" href=\"#H899949213\">",
"       'Cystitis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For outpatient treatment of uncomplicated pyelonephritis we suggest",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"       ciprofloxacin",
"      </a>",
"      (500 mg orally twice daily for seven days or 1000 mg extended release once daily for seven days) or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"       levofloxacin",
"      </a>",
"      (750 mg orally once daily for five to seven days) (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). The bioavailability and urinary penetration of fluoroquinolones with oral dosing is comparable to intravenous dosing. In women who have severe pyelonephritis, live in areas where the prevalence of fluoroquinolone resistance is known or suspected to exceed 10 percent, have other risk factors for fluoroquinolone resistance as described above, or cannot tolerate oral fluoroquinolone therapy, intravenous therapy with a long-acting parenteral antimicrobial such as",
"      <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"       ceftriaxone",
"      </a>",
"      (1 gram) or an aminoglycoside (consolidated 24 hour dose) should be administered until susceptibility data are available. Subsequent therapy should be guided by susceptibility data. (See",
"      <a class=\"local\" href=\"#H899949220\">",
"       'Pyelonephritis'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?8/30/8679?source=see_link\">",
"       \"Consolidated aminoglycoside dosing with gentamicin and tobramycin\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/1\">",
"      Gupta K, Hooton TM, Naber KG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011; 52:e103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/2\">",
"      Hooton TM, Scholes D, Hughes JP, et al. A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996; 335:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/3\">",
"      Scholes D, Hooton TM, Roberts PL, et al. Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med 2005; 142:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/4\">",
"      Jackson SL, Boyko EJ, Scholes D, et al. Predictors of urinary tract infection after menopause: a prospective study. Am J Med 2004; 117:903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/5\">",
"      Czaja CA, Scholes D, Hooton TM, Stamm WE. Population-based epidemiologic analysis of acute pyelonephritis. Clin Infect Dis 2007; 45:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/6\">",
"      Echols RM, Tosiello RL, Haverstock DC, Tice AD. Demographic, clinical, and treatment parameters influencing the outcome of acute cystitis. Clin Infect Dis 1999; 29:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/7\">",
"      Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med 2012; 366:1028.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/8\">",
"      Gupta K, Trautner B. In the clinic. Urinary tract infection. Ann Intern Med 2012; 156:ITC3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/9\">",
"      Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 2003; 22 Suppl 2:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/10\">",
"      Kahlmeter G, ECO.SENS. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother 2003; 51:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/11\">",
"      Naber KG, Schito G, Botto H, et al. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol 2008; 54:1164.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/12\">",
"      Zhanel GG, Hisanaga TL, Laing NM, et al. Antibiotic resistance in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 2006; 27:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/13\">",
"      Sanchez GV, Master RN, Karlowsky JA, Bordon JM. In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010. Antimicrob Agents Chemother 2012; 56:2181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/14\">",
"      Swami SK, Liesinger JT, Shah N, et al. Incidence of antibiotic-resistant Escherichia coli bacteriuria according to age and location of onset: a population-based study from Olmsted County, Minnesota. Mayo Clin Proc 2012; 87:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/15\">",
"      Gupta K, Hooton TM, Miller L, Uncomplicated UTI IDSA Guideline Committee. Managing uncomplicated urinary tract infection--making sense out of resistance data. Clin Infect Dis 2011; 53:1041.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/16\">",
"      Richards DA, Toop LJ, Chambers ST, et al. Antibiotic resistance in uncomplicated urinary tract infection: problems with interpreting cumulative resistance rates from local community laboratories. N Z Med J 2002; 115:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/17\">",
"      Ti TY, Kumarasinghe G, Taylor MB, et al. What is true community-acquired urinary tract infection? Comparison of pathogens identified in urine from routine outpatient specimens and from community clinics in a prospective study. Eur J Clin Microbiol Infect Dis 2003; 22:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/18\">",
"      Brown PD, Freeman A, Foxman B. Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan. Clin Infect Dis 2002; 34:1061.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/19\">",
"      Metlay JP, Strom BL, Asch DA. Prior antimicrobial drug exposure: a risk factor for trimethoprim-sulfamethoxazole-resistant urinary tract infections. J Antimicrob Chemother 2003; 51:963.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/20\">",
"      Colgan R, Johnson JR, Kuskowski M, Gupta K. Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis. Antimicrob Agents Chemother 2008; 52:846.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/21\">",
"      Olson RP, Harrell LJ, Kaye KS. Antibiotic resistance in urinary isolates of Escherichia coli from college women with urinary tract infections. Antimicrob Agents Chemother 2009; 53:1285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/22\">",
"      Gupta K. Emerging antibiotic resistance in urinary tract pathogens. Infect Dis Clin North Am 2003; 17:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/23\">",
"      Raz R, Chazan B, Kennes Y, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002; 34:1165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/24\">",
"      Miller LG, Tang AW. Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance. Mayo Clin Proc 2004; 79:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/25\">",
"      Talan DA, Krishnadasan A, Abrahamian FM, et al. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fluoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008; 47:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/26\">",
"      Paterson DL. \"Collateral damage\" from cephalosporin or quinolone antibiotic therapy. Clin Infect Dis 2004; 38 Suppl 4:S341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/27\">",
"      Schito GC, Naber KG, Botto H, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents 2009; 34:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/28\">",
"      Ho PL, Yip KS, Chow KH, et al. Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008. Diagn Microbiol Infect Dis 2010; 66:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/29\">",
"      Bent S, Nallamothu BK, Simel DL, et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002; 287:2701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/30\">",
"      Fairley KF, Carson NE, Gutch RC, et al. Site of infection in acute urinary-tract infection in general practice. Lancet 1971; 2:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/31\">",
"      Stamm WE. Measurement of pyuria and its relation to bacteriuria. Am J Med 1983; 75:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/32\">",
"      Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004; 38:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/33\">",
"      Pappas PG. Laboratory in the diagnosis and management of urinary tract infections. Med Clin North Am 1991; 75:313.",
"     </a>",
"    </li>",
"    <li>",
"     Eisenstadt J, Washington JA. Diagnostic microbiology for bacteria and yeasts causing urinary tract infections. In: UTIs: Molecular Pathogenesis and Clinical Management, Mobley HL, Warren JW (Eds), ASM Press, Washington, DC 1996. p.29.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/35\">",
"      Warren JW, Abrutyn E, Hebel JR, et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). Clin Infect Dis 1999; 29:745.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/36\">",
"      Fihn SD. Clinical practice. Acute uncomplicated urinary tract infection in women. N Engl J Med 2003; 349:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/37\">",
"      McIsaac WJ, Low DE, Biringer A, et al. The impact of empirical management of acute cystitis on unnecessary antibiotic use. Arch Intern Med 2002; 162:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/38\">",
"      Gupta K, Hooton TM, Stamm WE. Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections. Ann Intern Med 2001; 135:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/39\">",
"      Gupta K, Hooton TM, Roberts PL, Stamm WE. Short-course nitrofurantoin for the treatment of acute uncomplicated cystitis in women. Arch Intern Med 2007; 167:2207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/40\">",
"      Iravani A, Klimberg I, Briefer C, et al. A trial comparing low-dose, short-course ciprofloxacin and standard 7 day therapy with co-trimoxazole or nitrofurantoin in the treatment of uncomplicated urinary tract infection. J Antimicrob Chemother 1999; 43 Suppl A:67.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/41\">",
"      Stein GE. Comparison of single-dose fosfomycin and a 7-day course of nitrofurantoin in female patients with uncomplicated urinary tract infection. Clin Ther 1999; 21:1864.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/42\">",
"      McKinnell JA, Stollenwerk NS, Jung CW, Miller LG. Nitrofurantoin compares favorably to recommended agents as empirical treatment of uncomplicated urinary tract infections in a decision and cost analysis. Mayo Clin Proc 2011; 86:480.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/43\">",
"      Arredondo-Garc&iacute;a JL, Figueroa-Dami&aacute;n R, Rosas A, et al. Comparison of short-term treatment regimen of ciprofloxacin versus long-term treatment regimens of trimethoprim/sulfamethoxazole or norfloxacin for uncomplicated lower urinary tract infections: a randomized, multicentre, open-label, prospective study. J Antimicrob Chemother 2004; 54:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/44\">",
"      Kavatha D, Giamarellou H, Alexiou Z, et al. Cefpodoxime-proxetil versus trimethoprim-sulfamethoxazole for short-term therapy of uncomplicated acute cystitis in women. Antimicrob Agents Chemother 2003; 47:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/45\">",
"      Fosfomycin for urinary tract infections. Med Lett Drugs Ther 1997; 39:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/46\">",
"      Ferry SA, Holm SE, Stenlund H, et al. Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project. Scand J Prim Health Care 2007; 25:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/47\">",
"      Nicolle LE, Madsen KS, Debeeck GO, et al. Three days of pivmecillinam or norfloxacin for treatment of acute uncomplicated urinary infection in women. Scand J Infect Dis 2002; 34:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/48\">",
"      Graninger W. Pivmecillinam--therapy of choice for lower urinary tract infection. Int J Antimicrob Agents 2003; 22 Suppl 2:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/49\">",
"      Hooton TM, Besser R, Foxman B, et al. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin Infect Dis 2004; 39:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/50\">",
"      Henry D, Ellison W, Sullivan J, et al. Treatment of community-acquired acute uncomplicated urinary tract infection with sparfloxacin versus ofloxacin. The Sparfloxacin Multi Center UUTI Study Group. Antimicrob Agents Chemother 1998; 42:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/51\">",
"      Richard GA, Mathew CP, Kirstein JM, et al. Single-dose fluoroquinolone therapy of acute uncomplicated urinary tract infection in women: results from a randomized, double-blind, multicenter trial comparing single-dose to 3-day fluoroquinolone regimens. Urology 2002; 59:334.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/52\">",
"      Fourcroy JL, Berner B, Chiang YK, et al. Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women. Antimicrob Agents Chemother 2005; 49:4137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/53\">",
"      Henry DC Jr, Bettis RB, Riffer E, et al. Comparison of once-daily extended-release ciprofloxacin and conventional twice-daily ciprofloxacin for the treatment of uncomplicated urinary tract infection in women. Clin Ther 2002; 24:2088.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/54\">",
"      Vogel T, Verreault R, Gourdeau M, et al. Optimal duration of antibiotic therapy for uncomplicated urinary tract infection in older women: a double-blind randomized controlled trial. CMAJ 2004; 170:469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/55\">",
"      Auquer F, Cord&oacute;n F, Gorina E, et al. Single-dose ciprofloxacin versus 3 days of norfloxacin in uncomplicated urinary tract infections in women. Clin Microbiol Infect 2002; 8:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/56\">",
"      Hooton TM, Scholes D, Gupta K, et al. Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 2005; 293:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/57\">",
"      Akyar I. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital]. Mikrobiyol Bul 2008; 42:713.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/58\">",
"      Rodr&iacute;guez-Ba&ntilde;o J, Alcal&aacute; JC, Cisneros JM, et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch Intern Med 2008; 168:1897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/59\">",
"      Hooton TM, Roberts PL, Stapleton AE. Cefpodoxime vs ciprofloxacin for short-course treatment of acute uncomplicated cystitis: a randomized trial. JAMA 2012; 307:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/60\">",
"      Little P, Moore MV, Turner S, et al. Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial. BMJ 2010; 340:c199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/61\">",
"      Bleidorn J, G&aacute;gyor I, Kochen MM, et al. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?--results of a randomized controlled pilot trial. BMC Med 2010; 8:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/62\">",
"      Ward G, Jorden RC, Severance HW. Treatment of pyelonephritis in an observation unit. Ann Emerg Med 1991; 20:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/63\">",
"      Talan DA, Stamm WE, Hooton TM, et al. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA 2000; 283:1583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/64\">",
"      Peterson J, Kaul S, Khashab M, et al. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. Urology 2008; 71:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/65\">",
"      Talan DA, Klimberg IW, Nicolle LE, et al. Once daily, extended release ciprofloxacin for complicated urinary tract infections and acute uncomplicated pyelonephritis. J Urol 2004; 171:734.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/66\">",
"      Sandberg T, Skoog G, Hermansson AB, et al. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial. Lancet 2012; 380:484.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/67\">",
"      Vellinga A, Tansey S, Hanahoe B, et al. Trimethoprim and ciprofloxacin resistance and prescribing in urinary tract infection associated with Escherichia coli: a multilevel model. J Antimicrob Chemother 2012; 67:2523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/68\">",
"      Sanchez M, Collvinent B, Mir&oacute; O, et al. Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial. Emerg Med J 2002; 19:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/69\">",
"      Cronberg S, Banke S, Bergman B, et al. Fewer bacterial relapses after oral treatment with norfloxacin than with ceftibuten in acute pyelonephritis initially treated with intravenous cefuroxime. Scand J Infect Dis 2001; 33:339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/70\">",
"      Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010; 70:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/71\">",
"      Suankratay C, Jutivorakool K, Jirajariyavej S. A prospective study of ceftriaxone treatment in acute pyelonephritis caused by extended-spectrum beta-lactamase-producing bacteria. J Med Assoc Thai 2008; 91:1172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/72\">",
"      Mombelli G, Pezzoli R, Pinoja-Lutz G, et al. Oral vs intravenous ciprofloxacin in the initial empirical management of severe pyelonephritis or complicated urinary tract infections: a prospective randomized clinical trial. Arch Intern Med 1999; 159:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?13/15/13561/abstract/73\">",
"      Klimberg I, Shockey G, Ellison H, et al. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study. Curr Med Res Opin 2005; 21:1241.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8063 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"footerNav\">",
"   <ul>",
"    <li>",
"     <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Wolters Kluwer Health",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Facts &amp; Comparisons&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"      Medi-Span&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"      ProVation&reg; Order Sets",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"      ProVation&reg; Medical",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Pharmacy OneSource&reg;",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"      Medicom",
"     </a>",
"    </li>",
"    <li>",
"     <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"      Lexicomp",
"     </a>",
"    </li>",
"    <li class=\"last\">",
"     <a href=\"/home/privacy-policy\">",
"      Privacy Policy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <div id=\"footerLogo\">",
"   <a href=\"./toc\">",
"    Wolters Kluwer Health | UpToDate",
"   </a>",
"  </div>",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"sfInfo\">",
"    <a href=\"/home/terms-use\">",
"     Terms of Use",
"    </a>",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     UpToDate Marketing Professional",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-113.200.70.15-4679487243-14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13561=[""].join("\n");
var outline_f13_15_13561=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H899949262\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949128\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949142\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949149\">",
"      PATHOGENESIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949156\">",
"      MICROBIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H899949163\">",
"      Antimicrobial resistance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949170\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949177\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H899949184\">",
"      Urinalysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H899949191\">",
"      Urine culture",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1425706\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949198\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H899949213\">",
"      Cystitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H899949220\">",
"      Pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H899949227\">",
"      - Outpatient",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H899949234\">",
"      - Inpatient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H899949241\">",
"      Follow-up",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H899949248\">",
"      Symptomatic therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H899949262\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/47/10999?source=related_link\">",
"      Acute complicated cystitis and pyelonephritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/7/15479?source=related_link\">",
"      Acute uncomplicated cystitis, pyelonephritis, and asymptomatic bacteriuria in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/49/36633?source=related_link\">",
"      Approach to women with symptoms of vaginitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/0/1032?source=related_link\">",
"      Clinical features and diagnosis of pelvic inflammatory disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/30/10729?source=related_link\">",
"      Clinical manifestations and diagnosis of Chlamydia trachomatis infections",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/30/8679?source=related_link\">",
"      Consolidated aminoglycoside dosing with gentamicin and tobramycin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/50/20266?source=related_link\">",
"      Diagnosis and acute management of suspected nephrolithiasis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/53/30553?source=related_link\">",
"      Extended-spectrum beta-lactamases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/8/8330?source=related_link\">",
"      Pathogenesis, clinical features, and diagnosis of interstitial cystitis/bladder pain syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?27/25/28048?source=related_link\">",
"      Patient information: Kidney infection (pyelonephritis) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?31/18/32036?source=related_link\">",
"      Patient information: Urinary tract infections in adolescents and adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20210?source=related_link\">",
"      Patient information: Urinary tract infections in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/15/26873?source=related_link\">",
"      Urethral diverticulum in women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/34/22058?source=related_link\">",
"      Urinalysis in the diagnosis of kidney disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?23/41/24214?source=related_link\">",
"      Urine sampling and culture in the diagnosis of urinary tract infection in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f13_15_13562="Ectopic pregnancy 1";
var content_f13_15_13562=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F55800%7EOBGYN%2F62515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F55800%7EOBGYN%2F62515&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Six week ectopic pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Aron Schuftan, MD. Copyright &copy; Aron Schuftan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Six week ectopic pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 312px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The fallopian tube has been opened to reveal the gestational sac.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Aron Schuftan, MD. Copyright &copy; Aron Schuftan, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13562=[""].join("\n");
var outline_f13_15_13562=null;
var title_f13_15_13563="Meta anal surveillance CRC surg";
var content_f13_15_13563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F77401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F77401&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Meta-analyses of intensive versus less intensive surveillance after potentially curative therapy for colon and rectum cancer",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Author, year",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Pooled number of patients in randomized trials",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Relative risk for mortality (95% CI)&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Intensive",
"       </td>",
"       <td class=\"subtitle2\">",
"        Less intensive&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Renehan A; 2002",
"       </td>",
"       <td>",
"        666",
"       </td>",
"       <td>",
"        676",
"       </td>",
"       <td>",
"        0.81 (0.70-0.94)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Figueredo A; 2003",
"       </td>",
"       <td>",
"        858",
"       </td>",
"       <td>",
"        821",
"       </td>",
"       <td>",
"        0.80 (0.70-0.91)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Jeffery G; 2007",
"       </td>",
"       <td>",
"        793",
"       </td>",
"       <td>",
"        808",
"       </td>",
"       <td>",
"        0.73 (0.59-0.91)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13563=[""].join("\n");
var outline_f13_15_13563=null;
var title_f13_15_13564="Expression adhesion molecules";
var content_f13_15_13564=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F71824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F71824&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Adhesion molecules in leukocyte migration",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Adhesion molecule",
"       </td>",
"       <td class=\"subtitle1\">",
"        Cellular expression for leukocyte migration",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Integrins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        LFA-1 (CD11a/CD18b)",
"       </td>",
"       <td>",
"        Present on lymphocytes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Mac-1 (CR3, CD11b/CD18b)",
"       </td>",
"       <td>",
"        Present on neutrophils and monocytes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        gp 150/95 (CD11c/CD18b)",
"       </td>",
"       <td>",
"        Present on neutrophils and monocytes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        VLA-4 (very late antigen-4)",
"       </td>",
"       <td>",
"        Present on lymphocytes, monocytes, and eosinophils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Immunoglobulin superfamily",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"2\">",
"        ICAM-1",
"       </td>",
"       <td>",
"        Low level constitutive endothelial cell expression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased endothelial cell expression with stimulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"2\">",
"        ICAM-2",
"       </td>",
"       <td>",
"        High level constitutive endothelial cell expression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No increase with stimulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"2\">",
"        VCAM-1",
"       </td>",
"       <td>",
"        No constitutive endothelial cell expression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Increased endothelial cell expression with stimulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Selectins",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        P-selectin",
"       </td>",
"       <td>",
"        Platelet and endothelial cell surface expression after stimulation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        E-selectin",
"       </td>",
"       <td>",
"        Exclusively expressed on stimulated endothelial cells",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"1\" rowspan=\"2\">",
"        L-selectin",
"       </td>",
"       <td>",
"        Constitutively expressed on neutrophils, monocytes, and a T cell subset",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shed from neutrophils after stimulation with chemoattractants",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13564=[""].join("\n");
var outline_f13_15_13564=null;
var title_f13_15_13565="Causes of longitudinal melanonychia 2";
var content_f13_15_13565=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F85615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F85615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Longitudinal melanonychia: Conditions associated with melanocytic activation and hyperplasia",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Melanocytic activation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Physiologic causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Racial melanonychia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Pregnancy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Local and regional causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Repeated local trauma from poor footwear or overriding toes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Onychotillomania",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nail biting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Occupational trauma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Carpal tunnel syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Dermatologic causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Psoriasis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lichen planus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Amyloidosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chronic radiation dermatitis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Systemic lupus erythematosus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Localized scleroderma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Chronic paronychia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Onychomycosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Onychomatricoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Bowen disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Myxoid pseudocyst",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Basal cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Subungual fibrous histiocytoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Verruca vulgaris",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Systemic causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Endocrine disorders (Addison disease, Cushing syndrome, Nelson syndrome, hyperthyroidism, acromegaly)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Alcaptonuria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Nutritional disorders",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hemosiderosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hyperbilirubinemia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Porphyria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Graft vs. host disease (lichen planus-type changes accompanied by longitudinal melanonychia)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        AIDS",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Iatrogenic causes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Phototherapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        X-ray exposure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Electron beam therapy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Drug intake",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Syndromes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Laugier-Hunziker syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Peutz-Jegher syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Touraine syndrome",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Melanocytic hyperplasia",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Lentigo",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Nevus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Congenital nevi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Acquired nevi",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\">",
"        Nail apparatus in-situ and invasive melanoma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Source: Andr&eacute; J, Lateur N. Pigmented nail disorders. Dermatol Clin 2006; 24:329.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13565=[""].join("\n");
var outline_f13_15_13565=null;
var title_f13_15_13566="Contents: Principles of anesthesia and analgesia";
var content_f13_15_13566=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ���������������������������",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?5/48/5902\">",
"       General Surgery",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Principles of anesthesia and analgesia",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Principles of anesthesia and analgesia",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <strong>",
"         Acute pain management",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?26/57/27546\">",
"           Management of postoperative pain",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anesthesia evaluation",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/22/19817\">",
"           Overview of anesthesia and anesthetic choices",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anesthesia medications",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/51/34618\">",
"           Procedural sedation in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anesthesia methods",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?34/41/35482\">",
"           Anesthesia for the obese patient undergoing non-cardiac surgery",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/22/19817\">",
"           Overview of anesthesia and anesthetic choices",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Anesthesia procedures",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/33/15894\">",
"           Arterial blood gases",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?25/51/26424\">",
"           Arterial catheterization techniques for invasive monitoring",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?0/1/29\">",
"           Complications of central venous catheters and their prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/9/23703\">",
"           Digital nerve block",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?4/50/4905\">",
"           Emergent surgical cricothyrotomy (cricothyroidotomy)",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?19/6/19561\">",
"           Lumbar puncture: Technique; indications; contraindications; and complications in adults",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?43/32/44553\">",
"           Overview of central venous access",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/37/5719\">",
"           Overview of peripheral nerve blocks",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?17/39/18042\">",
"           Peripheral nerve block: Techniques",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?3/14/3306\">",
"           Placement of jugular venous catheters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/27/1466\">",
"           Placement of subclavian venous catheters",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?20/61/21465\">",
"           Temporary cardiac pacing",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?13/35/13877\">",
"           Venous blood gases and other alternatives to arterial blood gases",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Chronic pain management",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?31/37/32344\">",
"           Etiology, clinical manifestations, and diagnosis of complex regional pain syndrome in adults",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Complications of anesthesia",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/4/35912\">",
"           Acute urinary retention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/44/34504\">",
"           Awareness with recall following general anesthesia",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?32/13/32984\">",
"           Malignant hyperthermia: Clinical diagnosis and management of acute crisis",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?36/3/36921\">",
"           Susceptibility to malignant hyperthermia",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Intraoperative management",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?41/46/42729\">",
"           Intraoperative fluid management",
"          </a>",
"         </li>",
"        </ul>",
"        <strong>",
"         Postoperative care",
"        </strong>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?33/2/33834\">",
"           Overview of complications occurring in the post-anesthesia care unit",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?39/61/40920\">",
"           Pain control in the critically ill adult patient",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0505-95.154.198.148-8378E94AFC-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f13_15_13566=[""].join("\n");
var outline_f13_15_13566=null;
var title_f13_15_13567="Color Doppler TEE aortic rupture";
var content_f13_15_13567=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F63464&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F63464&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Transesophageal echocardiogram with color Doppler of aortic rupture",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 385px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Transesophageal echocardiogram with color Doppler flow mapping of aortic rupture showing similar blood flow velocities on both sides of the medial flap, and a mosaic of colors at the site of the disruption due to blood flow turbulence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of P Vignon, MD and RM Lang, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f13_15_13567=[""].join("\n");
var outline_f13_15_13567=null;
